EX-10.2



 Exhibit 10.2 

PLEDGE AND SECURITY AGREEMENT 

THIS PLEDGE AND SECURITY AGREEMENT (as it may be amended, restated, supplemented or otherwise modified from time to time, this
“Security Agreement”) is entered into as of July 27, 2017 by and among Heska Corporation, a Delaware corporation, Diamond Animal Health, Inc., an Iowa corporation, Heska Imaging, LLC, a Delaware limited liability company, (each
a “Grantor”, and collectively, the “Grantors”), and JPMorgan Chase Bank, N.A., in its capacity as administrative agent (the “Administrative Agent”) for the lenders party to the Credit Agreement
referred to below. 
 PRELIMINARY STATEMENT 

The Grantors, the Administrative Agent, any other Loan Parties and the Lenders are entering into a Credit Agreement dated as of the date
hereof (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Each Grantor is entering into this Security Agreement in order to induce the Lenders to enter into and extend
credit to the Grantor under the Credit Agreement. 
 ACCORDINGLY, the Grantors and the Administrative Agent, on behalf of the Secured
Parties, hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 
 1.1. Terms
Defined in Credit Agreement. All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Credit Agreement. 

1.2. Terms Defined in UCC. Terms defined in the UCC which are not otherwise defined in this Security Agreement are used herein as
defined in the UCC. 
 1.3. Definitions of Certain Terms Used Herein. As used in this Security Agreement, in addition to the terms
defined in the first paragraph hereof and in the Preliminary Statement, the following terms shall have the following meanings: 

“Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Article” means a numbered article of this Security Agreement, unless another document is specifically referenced. 

“Chattel Paper” shall have the meaning set forth in Article 9 of the UCC. 

“Closing Date” means the date of the Credit Agreement. 

“Collateral” shall have the meaning set forth in Article II. 

“Collateral Access Agreement” means any landlord waiver or other agreement, in form and substance satisfactory to the
Administrative Agent, between the Administrative Agent and any third party (including any bailee, consignee, customs broker, or other similar Person) in possession of any Collateral or any landlord of any real property where any Collateral is
located, as such landlord waiver or other agreement may be amended, restated, supplemented or otherwise modified from time to time. 

“Commercial Tort Claims” means the commercial tort claims as defined in Article 9 of the UCC, including each commercial tort
claim specifically described on Exhibit I. 







 “Control” shall have the meaning set forth in Article 8 or, if applicable, in Section 9-104, 9-105, 9-106 or 9-107 of Article 9 of the UCC. 

“Copyrights” means, with respect to any Person, all of such Person’s right, title, and interest in and to the following:
(a) all copyrights, rights and interests in copyrights, works protectable by copyright, copyright registrations, and copyright applications; (b) all renewals of any of the foregoing; (c) all income, royalties, damages, and payments
now or hereafter due and/or payable under any of the foregoing, including, without limitation, damages or payments for past or future infringements for any of the foregoing; (d) the right to sue for past, present, and future infringements of
any of the foregoing; and (e) all rights corresponding to any of the foregoing throughout the world. 
 “Default”
means any event or condition which constitutes an Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 

“Deposit Account Control Agreement” means an agreement, in form and substance satisfactory to the Administrative Agent, among
any Loan Party, a banking institution holding such Loan Party’s funds, and the Administrative Agent with respect to collection and control of all deposits and balances held in a deposit account maintained by such Loan Party with such banking
institution. 
 “Deposit Accounts” shall have the meaning set forth in Article 9 of the UCC. 

“Documents” shall have the meaning set forth in Article 9 of the UCC. 

“Equipment” shall have the meaning set forth in Article 9 of the UCC. 

“Event of Default” means an event described in Section 5.1. 

“Excluded Collateral” means, collectively, (a) any rights or interest in any contract, lease, permit, license, or
license agreement covering real or personal property if under the terms of such contract, lease, permit, license, or license agreement, or applicable law with respect thereto, the grant of a security interest or lien therein is prohibited or
restricted as a matter of law or under the terms of such contract, lease, permit, license, or license agreement , or would invalidate any such contract, lease, permit, license or license agreement, and such prohibition or restriction has not been
waived or the consent of the other party to such contract, lease, permit, license, or license agreement has not been obtained (provided, that, (i) the foregoing exclusions of this clause (a) shall in no way be construed (A) to
apply to the extent that any described prohibition or restriction is ineffective under Section 9-406, 9-407, 9-408, or 9-409 of the UCC or other applicable law, or (B) to apply to the extent that any consent or waiver has been obtained that would permit the Administrative Agent’s security interest or lien to attach
notwithstanding the prohibition or restriction on the pledge of such contract, lease, permit, license, or license agreement and (ii) the foregoing exclusions of clause (a) shall in no way be construed to limit, impair, or otherwise affect
any of the Administrative Agent’s or any Lender’s continuing security interests in and liens upon any rights or interests of any Grantor in or to (A) monies due or to become due under or in connection with any described contract,
lease, permit, license, license agreement, or (B) any proceeds from the sale, license, lease, or other dispositions of any such contract, lease, permit, license, or license agreement); (b) any United States intent-to-use trademark or service mark applications to the extent that, and solely during the period in which, the grant of a security interest therein would impair the validity or enforceability of a
registration issuing from such intent-to-use trademark or service mark applications under applicable federal law, provided that upon submission and acceptance by the
United States Patent and Trademark Office of an amendment to allege use pursuant to 15 U.S.C. Section 1051(c) or a statement of use pursuant to 15 U.S.C. Section 1051(d) (or any successor provisions), such intent-to-use trademark or service mark application shall be considered Collateral; (c) any interest in any real property held by any Grantor; and (d) Excluded Deposit and Securities Accounts. 

  
 2 








 “Excluded Deposit and Securities Accounts” means the collective reference to:
(a) Deposit Accounts of Grantors specially and exclusively used for payroll, payroll taxes, trust or fiduciary purposes and other employee wage and benefit payments to or for the Grantors’ employees (provided that the amount on deposit in
such accounts does not exceed the then current amount of such payroll, payroll taxes and other employee wage and benefit obligations), and (b) Deposit Accounts specially and exclusively used for taxes, including sales taxes (provided that the
amount on deposit in such accounts does not exceed the then current amount of such tax obligations). 
 “Exhibit” refers to
a specific exhibit to this Security Agreement, unless another document is specifically referenced. 
 “Farm Products” shall
have the meaning set forth in Article 9 of the UCC. 
 “Fixtures” shall have the meaning set forth in Article 9 of the UCC.

 “General Intangibles” shall have the meaning set forth in Article 9 of the UCC. 

“Goods” shall have the meaning set forth in Article 9 of the UCC. 

“Instruments” shall have the meaning set forth in Article 9 of the UCC. 

“Inventory” shall have the meaning set forth in Article 9 of the UCC. 

“Investment Property” shall have the meaning set forth in Article 9 of the UCC. 

“Lenders” means the lenders party to the Credit Agreement and their successors and assigns. 

“Letter-of-Credit Rights” shall have the
meaning set forth in Article 9 of the UCC. 
 “Licenses” means, with respect to any Person, all of such Person’s
right, title, and interest in and to (a) any and all written licensing agreements or similar arrangements in and to its Patents, Copyrights, or Trademarks, (b) all income, royalties, damages, claims, and payments now or hereafter due or
payable under and with respect thereto, including, without limitation, damages and payments for past and future breaches thereof, and (c) all rights to sue for past, present, and future breaches thereof. 

“Patents” means, with respect to any Person, all of such Person’s right, title, and interest in and to: (a) any and
all patents and patent applications; (b) all inventions and improvements described and claimed therein; (c) all reissues, divisions, continuations, renewals, extensions, and
continuations-in-part thereof; (d) all income, royalties, damages, claims, and payments now or hereafter due or payable under and with respect thereto, including,
without limitation, damages and payments for past and future infringements thereof; (e) all rights to sue for past, present, and future infringements thereof; and (f) all rights corresponding to any of the foregoing throughout the world.

 “Pledged Collateral” means all Instruments, Securities and other Investment Property of the Grantors, to the extent
constituting Collateral, whether or not physically delivered to the Administrative Agent pursuant to this Security Agreement. 

“Receivables” means the Accounts, Chattel Paper, Documents, Investment Property, Instruments and any other rights or claims
to receive money which are General Intangibles or which are otherwise included as Collateral. 
 “Section” means a numbered
section of this Security Agreement, unless another document is specifically referenced. 

  
 3 








 “Secured Parties” shall have the meaning set forth in the Credit Agreement. 

“Security” shall have the meaning set forth in Article 8 of the UCC. 

“Stock Rights” means all dividends, instruments or other distributions and any other right or property which the Grantors
shall receive or shall become entitled to receive for any reason whatsoever with respect to, in substitution for or in exchange for any Equity Interest constituting Collateral, any right to receive an Equity Interest and any right to receive
earnings, in which the Grantors now have or hereafter acquire any right, issued by an issuer of such Equity Interest. 
 “Supporting
Obligations” shall have the meaning set forth in Article 9 of the UCC. 
 “Trademarks” means, with respect to any
Person, all of such Person’s right, title, and interest in and to the following: (a) all trademarks (including service marks), trade names, trade dress, and trade styles and the registrations and applications for registration thereof and
the goodwill of the business symbolized by the foregoing; (b) all licenses of the foregoing, whether as licensee or licensor; (c) all renewals of the foregoing; (d) all income, royalties, damages, and payments now or hereafter due or
payable with respect thereto, including, without limitation, damages, claims, and payments for past and future infringements thereof; (e) all rights to sue for past, present, and future infringements of the foregoing, including the right to
settle suits involving claims and demands for royalties owing; and (f) all rights corresponding to any of the foregoing throughout the world. 

“UCC” means the Uniform Commercial Code, as in effect from time to time, of the State of New York or of any other state the
laws of which are required as a result thereof to be applied in connection with the attachment, perfection or priority of, or remedies with respect to, Administrative Agent’s or any other Secured Party’s Lien on any Collateral. 

The foregoing definitions shall be equally applicable to both the singular and plural forms of the defined terms. 

ARTICLE II 
 GRANT OF
SECURITY INTEREST 
 Each Grantor hereby pledges, collaterally assigns and grants to the Administrative Agent, on behalf of and for the
ratable benefit of the Secured Parties, a security interest in all of its right, title and interest in, to and under the following personal property and assets, whether now owned by or owing to, or hereafter acquired by or arising in favor of such
Grantor (including under any trade name or derivations thereof), and whether owned or consigned by or to, or leased from or to, such Grantor, and regardless of where located (all of which will be collectively referred to as the
“Collateral”): 
  

	 	(i)	all Accounts; 

  

	 	(ii)	all Chattel Paper; 

  

	 	(iii)	all Copyrights, Patents and Trademarks; 

  

	 	(iv)	all Documents; 

  

	 	(v)	all Equipment; 

  

	 	(vi)	all Fixtures; 

  

	 	(vii)	all General Intangibles; 

  

	 	(viii)	all Goods; 

  

	 	(ix)	all Instruments; 


  
 4 









	 	(x)	all Inventory; 

  

	 	(xi)	all Investment Property; 

  

	 	(xii)	all cash or cash equivalents; 

  

	 	(xiii)	all letters of credit, Letter-of-Credit Rights and Supporting Obligations; 


 

	 	(xiv)	all Deposit Accounts with any bank or other financial institution; 

  

	 	(xv)	all Commercial Tort Claims; 

  

	 	(xvi)	all Farm Products; and 

  

	 	(xvii)	all accessions to, substitutions for and replacements, proceeds (including Stock Rights), insurance proceeds and products of the foregoing, together with all books and records, customer lists, credit files, computer
files, programs, printouts and other computer materials and records related thereto and any General Intangibles at any time evidencing or relating to any of the foregoing; 


to secure the prompt and complete payment and performance of the Secured Obligations. 

Notwithstanding anything contained in this Security Agreement to the contrary, the term “Collateral” and the foregoing grant shall not include, and
the security interest shall not attach to, any Excluded Collateral, provided, that if and when any property shall cease to be Excluded Collateral, such property shall be deemed at all times from and after such date to constitute Collateral to the
extent subject to the grant clause in this Article II. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

Each Grantor represents and warrants to the Administrative Agent and the Secured Parties that: 

3.1. Title, Authorization, Validity, Enforceability, Perfection and Priority. Such Grantor has good and valid rights in or the power to
transfer the Collateral and title to the Collateral with respect to which it has purported to grant a security interest hereunder, free and clear of all Liens except for Liens permitted under Section 4.1(e), and has full power and authority to
grant to the Administrative Agent the security interest in the Collateral pursuant hereto. The execution and delivery by such Grantor of this Security Agreement has been duly authorized by proper corporate and limited liability company, as
applicable, proceedings of such Grantor, and this Security Agreement constitutes a legal valid and binding obligation of such Grantor and creates a security interest which is enforceable against such Grantor in all Collateral it now owns or
hereafter acquires, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in
equity or at law. When financing statements have been filed in the appropriate offices against such Grantor in the locations listed on Exhibit H, the Administrative Agent will have a fully perfected first priority security interest in that
Collateral of such Grantor in which a security interest may be perfected by such filings, subject only to Liens permitted under Section 4.1(e). 

3.2. Type and Jurisdiction of Organization, Organizational and Identification Numbers. The type of entity of such Grantor, its state of
organization, the organizational number issued to it by its state of organization and its federal employer identification number are set forth on Exhibit A. 

3.3. Principal Location. Such Grantor’s mailing address, which shall be its address for notices and other communications provided
for herein, and the location of its place of business (if it has only one) or its chief executive office (if it has more than one place of business), are disclosed in Exhibit A; such Grantor has no other places of business except those set
forth in Exhibit A. 

  
 5 








 3.4. Collateral Locations. All of such Grantor’s locations where Collateral in excess
of $50,000 in the aggregate is located (other than Collateral in transit in the ordinary course of business and personal property leased to customers pursuant to leases or Chattel Paper constituting Collateral) are listed on Exhibit A. All of
said locations are owned by such Grantor except for locations (i) which are leased by the Grantor as lessee and designated in Part VII(b) of Exhibit A and (ii) at which Inventory is held in a public warehouse or is otherwise
held by a bailee or on consignment as designated in Part VII(c) of Exhibit A. 
 3.5. Deposit Accounts. All of such
Grantor’s Deposit Accounts are listed on Exhibit B. 
 3.6. Exact Names. Such Grantor’s name in which it has
executed this Security Agreement is the exact name as it appears in such Grantor’s organizational documents, as amended, as filed with such Grantor’s jurisdiction of organization. Except as set forth in Exhibit A, Grantor has not, during
the past five years, been known by or used any other corporate or fictitious name, or been a party to any merger or consolidation, or been a party to any acquisition. 

3.7. Letter-of-Credit Rights and Chattel Paper.
Exhibit C lists all Letter-of-Credit Rights of such Grantor. All action by such Grantor necessary to protect and perfect the Administrative Agent’s Lien on
each item listed on Exhibit C has been duly taken by filing financing statements as directed in writing by the Administrative Agent. The Administrative Agent will have a fully perfected first priority security interest in the Collateral
listed on Exhibit C, subject only to Liens permitted under Section 4.1(e). Upon the request of the Administrative Agent, such Grantor will provide to the Administrative Agent a list of all Chattel Paper owned by such Grantor. Such
Grantor has not conveyed any interest in, or delivered possession of possession of, any Chattel Paper to any person and the originals of all Chattel Paper of such Grantor are in the possession of the Grantor at its principal place of business. 

3.8. Accounts and Chattel Paper. 

(a) The amounts owing, due dates and, to the knowledge of the Grantors, the correct legal names of the obligors and other information with
respect to its Accounts and Chattel Paper are and will be correctly stated in all material respects in all applicable records of such Grantor relating thereto and in all invoices with respect thereto furnished to the Administrative Agent by such
Grantor from time to time. As of the time when each Account or each item of Chattel Paper arises, such Grantor shall be deemed to have represented and warranted that such Account or Chattel Paper, as the case may be, and all records relating
thereto, are genuine and in all respects what they purport to be. 
 (b) With respect to its Accounts, (i) all Accounts represent bona
fide sales of Inventory or rendering of services to Account Debtors in the ordinary course of such Grantor’s business and are not evidenced by a judgment, Instrument or Chattel Paper; (ii) there are no material setoffs, claims or disputes
existing or asserted with respect thereto and such Grantor has not made any agreement with any Account Debtor for any extension of time for the payment thereof, any compromise or settlement for less than the full amount thereof, any release of any
Account Debtor from liability therefor, or any deduction therefrom except a discount or allowance allowed by such Grantor in the ordinary course of its business; (iii) to such Grantor’s knowledge, there are no facts, events or occurrences
which in any way materially impair the validity or enforceability thereof or could reasonably be expected to materially reduce the amount payable thereunder as shown on such Grantor’s books and records and any invoices, statements with respect
thereto; (iv) such Grantor has not received any written notice of proceedings or actions which are threatened or pending against any Account Debtor which are reasonably likely to result in any material adverse change in such Account
Debtor’s financial condition; and (v) such Grantor has no actual knowledge that any Account Debtor with respect to any material Accounts has become insolvent or is generally unable to pay its debts as they become due. 

(c) In addition, with respect to all of its Accounts, (i) the amounts shown on all invoices and statements with respect thereto are
actually and absolutely owing to such Grantor as indicated thereon and are not in any way contingent, and (ii) to such Grantor’s knowledge, all Account Debtors have the capacity to contract. 

  
 6 








 3.9. Inventory. With respect to any of its Inventory (a) such Inventory (other than
Inventory in transit) is located at one of such Grantor’s locations set forth on Exhibit A, (b) no Inventory (other than Inventory in transit) is now, or shall at any time or times hereafter be stored at any other location except as
permitted by Section 4.1(g), (c) such Grantor has good, indefeasible and merchantable title to such Inventory and such Inventory is not subject to any Lien or security interest or document whatsoever except for the security interest granted to
the Administrative Agent hereunder, for the benefit of the Administrative Agent and Secured Parties, and Permitted Encumbrances, (d) such Inventory is of good and merchantable quality, free from any known defects, (e) such Inventory is not
subject to any licensing, patent, royalty, trademark, trade name or copyright agreements with any third parties which would require any consent of any third party upon sale or disposition of that Inventory or the payment of any monies to any third
party upon such sale or other disposition, (f) such Inventory has been produced in accordance with the Federal Fair Labor Standards Act of 1938, as amended, and all rules, regulations and orders thereunder, and (g) the completion of
manufacture, sale or other disposition of such Inventory by the Administrative Agent following an Event of Default shall not require the consent of any Person and shall not constitute a breach or default under any contract or agreement to which such
Grantor is a party or to which such property is subject. 
 3.10. Intellectual Property. Such Grantor does not have any interest in,
or title to, any registered Patent, Trademark or Copyright except as set forth in Exhibit D. This Security Agreement is effective to create a valid and continuing Lien and, upon filing of appropriate financing statements in the offices listed
on Exhibit H and this Security Agreement with the United States Copyright Office and the United States Patent and Trademark Office, as applicable, fully perfected first priority security interests in favor of the Administrative Agent on such
Grantor’s U.S. Patents, Trademarks and Copyrights, such perfected security interests are enforceable as such as against any and all creditors of and purchasers from such Grantor, subject to applicable bankruptcy law and general principles of
equity. 
 3.11. Filing Requirements. None of its Equipment is covered by any certificate of title, except for the vehicles described
in Part I of Exhibit E. None of the Collateral owned by it is of a type for which security interests or liens may be perfected by filing under any federal statute except for (a) the vehicles described in Part II of Exhibit E and
(b) Patents, Trademarks and Copyrights held by such Grantor and described in Exhibit D. The legal description, county and street address of each property on which any Fixtures are located is set forth in Exhibit F together with
the name and address of the record owner of each such property. Notwithstanding anything contained in the Loan Documents to the contrary, as of the Effective Date, no Grantor shall be required to take any action required under the law of any non-U.S. jurisdiction to create or perfect any security interest in any Patents, Trademarks and Copyrights. 

3.12. No Financing Statements, Security Agreements. No effective financing statement or security agreement describing all or any
portion of the Collateral which has not lapsed or been terminated naming such Grantor as debtor has been filed or is of record in any jurisdiction except for financing statements or security agreements (a) naming the Administrative Agent on
behalf of the Secured Parties as the secured party and (b) in respect to other Liens permitted under Section 6.02 of the Credit Agreement. 

3.13. Pledged Collateral. 

(a) Exhibit G sets forth a complete and accurate list of all of the Pledged Collateral owned by such Grantor. Such Grantor is the direct, sole
beneficial owner and sole holder of record of the Pledged Collateral listed on Exhibit G as being owned by it, free and clear of any Liens, except for the security interest granted to the Administrative Agent for the benefit of the Secured Parties
hereunder and Permitted Encumbrances. Such Grantor further represents and warrants that (i) all Pledged Collateral owned by it constituting an Equity Interest has been (to the extent such concepts are relevant with respect to such Pledged
Collateral) duly authorized, validly issued, are fully paid and non-assessable, (ii) with respect to any certificates 

  
 7 








 
delivered to the Administrative Agent representing an Equity Interest, either such certificates are Securities as defined in Article 8 of the UCC as a result of actions by the issuer or
otherwise, or, if such certificates are not Securities, such Grantor has so informed the Administrative Agent so that the Administrative Agent may take steps to perfect its security interest therein as a General Intangible, (iii) all such
Pledged Collateral held by a securities intermediary is covered by a control agreement among such Grantor, the securities intermediary and the Administrative Agent pursuant to which the Administrative Agent has Control and (iv) to the knowledge
of the applicable Grantor, all Pledged Collateral which represents Indebtedness owed to such Grantor has been duly authorized, authenticated or issued and delivered by the issuer of such Indebtedness, is the legal, valid and binding obligation of
such issuer and such issuer (subject to debtor relief and bankruptcy laws and to general principles of equity) is not in default thereunder. 

(b) In addition, (i) none of the Pledged Collateral owned by it has been issued or transferred in violation of the securities
registration, securities disclosure or similar laws of any jurisdiction to which such issuance or transfer may be subject, (ii) no options, warrants, calls or commitments of any character whatsoever (A) exist relating to such Pledged
Collateral or (B) obligate the issuer of any Equity Interest included in the Pledged Collateral to issue additional Equity Interests, and (iii) no consent, approval, authorization, or other action by, and no giving of notice, filing with,
any governmental authority or any other Person is required for the pledge by such Grantor of such Pledged Collateral pursuant to this Security Agreement or for the execution, delivery and performance of this Security Agreement by such Grantor, or
for the exercise by the Administrative Agent of the voting or other rights provided for in this Security Agreement or for the remedies in respect of the Pledged Collateral pursuant to this Security Agreement, except as may be required in connection
with such disposition by laws affecting the offering and sale of securities generally. 
 (c) Except as set forth in Exhibit G, such
Grantor owns 100% of the issued and outstanding Equity Interests which constitute Pledged Collateral owned by it and none of the Pledged Collateral which represents Indebtedness owed to such Grantor is subordinated in right of payment to other
Indebtedness or subject to the terms of an indenture. 
 ARTICLE IV 

COVENANTS 
 From the date
of this Security Agreement, and thereafter until this Security Agreement is terminated, each Grantor agrees that: 
 4.1. General.

 (a) Collateral Records. Such Grantor will maintain complete and accurate books and records with respect to the Collateral owned by
it, and furnish to the Administrative Agent with sufficient copies for each of the Lenders, such reports relating to such Collateral as the Administrative Agent shall from time to time request. 

(b) Authorization to File Financing Statements; Ratification. Such Grantor hereby authorizes the Administrative Agent to file, and if
requested will deliver to the Administrative Agent, all financing statements and other documents and take such other actions as may from time to time be requested by the Administrative Agent in order to maintain a first perfected security interest
in and, if applicable, Control of, the Collateral owned by such Grantor. Any financing statement filed by the Administrative Agent may be filed in such offices as the Administrative Agent reasonably determines to be appropriate to perfect the
security interest of the Administrative Agent under this Security Agreement and may (i) indicate such Grantor’s Collateral (1) as all assets of the Grantor or words of similar effect, regardless of whether any particular asset
comprised in the Collateral falls within the scope of Article 9 of the UCC of such jurisdiction, or (2) by any other description which reasonably approximates the description contained in this Security Agreement, and (ii) contain any other
information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing statement or amendment, including (A) whether such Grantor is an organization,


  
 8 








 
the type of organization and any organization identification number issued to such Grantor, and (B) in the case of a financing statement filed as a fixture filing or indicating such
Grantor’s Collateral as as-extracted collateral or timber to be cut, a sufficient description of real property to which the Collateral relates. Such Grantor also agrees to furnish any such information
described in the foregoing sentence to the Administrative Agent promptly upon request. Such Grantor also ratifies its authorization for the Administrative Agent to have filed in any UCC jurisdiction any initial financing statements or amendments
thereto if filed prior to the date hereof. 
 (c) Further Assurances. Such Grantor will, if so requested by the Administrative Agent,
promptly furnish to the Administrative Agent, as often as the Administrative Agent reasonably requests, statements and schedules further identifying and describing the Collateral owned by it and such other reports and information in connection with
its Collateral as the Administrative Agent may reasonably request, all in such detail as the Administrative Agent may reasonably specify. Such Grantor also agrees to take any and all actions necessary to defend title to the Collateral against all
persons and to defend the security interest of the Administrative Agent in its Collateral and the priority thereof against any Lien not expressly permitted hereunder. 

(d) Disposition of Collateral. Such Grantor will not sell, lease or otherwise dispose of the Collateral except for dispositions
specifically permitted pursuant to Section 6.05 of the Credit Agreement. 
 (e) Liens. Such Grantor will not create, incur, or
suffer to exist any Lien on the Collateral except (i) the security interest created by this Security Agreement, and (ii) other Liens permitted under Section 6.02 of the Credit Agreement. 

(f) Other Financing Statements. Such Grantor will not authorize the filing of any financing statement naming it as debtor covering all
or any portion of the Collateral owned by it, except for financing statements (i) naming the Administrative Agent on behalf of the Secured Parties as the secured party, and (ii) in respect to other Liens permitted under Section 6.02
of the Credit Agreement. Such Grantor acknowledges that it is not authorized to file any financing statement or amendment or termination statement with respect to any financing statement referred to in clause (i) above without the prior written
consent of the Administrative Agent, subject to such Grantor’s rights under Section 9-509(d)(2) of the UCC. 

(g) Locations. Such Grantor will not (i) maintain any Collateral (other than Collateral in transit in the ordinary course of
business and personal property leased to customers pursuant to leases or Chattel Paper constituting Collateral) owned by it in excess of $50,000 in the aggregate at any location other than (x) those locations listed on Exhibit A and
(y) other locations promptly disclosed to Administrative Agent upon such Collateral being located at such location (and such Grantor will concurrently therewith obtain a Collateral Access Agreement for each such location to the extent required
by the Credit Agreement); or (ii) change its principal place of business or chief executive office from the location identified on Exhibit A, other than as permitted by the Credit Agreement. 

(h) Compliance with Terms. Such Grantor will perform and comply with all obligations in respect of the Collateral owned by it and all
agreements to which it is a party or by which it is bound relating to such Collateral. 
 4.2. Receivables. 

(a) Certain Agreements on Receivables. Such Grantor will not make or agree to make any material discount, credit, rebate or other
reduction in the original amount owing on a Receivable or accept in satisfaction of a Receivable less than the original amount thereof, except that, prior to the occurrence of an Event of Default, such Grantor may reduce the amount of Accounts
arising from the sale of Inventory in accordance with its present policies and in the ordinary course of business. 

  
 9 








 (b) Collection of Receivables. Except as otherwise provided in this Security Agreement,
such Grantor will collect and enforce, at such Grantor’s sole expense, all amounts due or hereafter due to such Grantor under the Receivables owned by it in accordance with past practice and in the ordinary course of business, subject to
discounts and allowances allowed by such Grantor in the ordinary course of its business. 
 (c) Delivery of Invoices. Such Grantor
will deliver to the Administrative Agent promptly upon its written request after the occurrence and during the continuation of an Event of Default duplicate invoices with respect to each Account owned by it and, after acceleration of the
Obligations, bearing such language of assignment as the Administrative Agent shall specify. 
 (d) Disclosure of Counterclaims on
Receivables. If (i) any material discount, credit or agreement to make a rebate or to otherwise reduce the amount owing on any Receivable owned by such Grantor exists or (ii) if, to the knowledge of such Grantor, any material dispute,
setoff, claim, counterclaim or defense exists or has been asserted or threatened with respect to any such Receivable, such Grantor will promptly disclose such fact to the Administrative Agent in writing. 

(e) Electronic Chattel Paper. Such Grantor shall take all steps requested by the Administrative Agent to grant the Administrative Agent
Control of all electronic chattel paper valued in excess of $50,000 in the aggregate for all such electronic chattel paper in accordance with the UCC and all “transferable records” as defined in each of the Uniform Electronic Transactions
Act and the Electronic Signatures in Global and National Commerce Act. 
 4.3. Inventory and Equipment. 

(a) Maintenance of Goods. Such Grantor will do all things necessary to maintain, preserve, protect and keep its Inventory and the
Equipment in good repair and working and saleable condition, except for damaged or defective goods arising in the ordinary course of such Grantor’s business and except for ordinary wear and tear in respect of the Equipment. 

(b) Returned Inventory. If an Account Debtor returns any Inventory to such Grantor when no Event of Default exists, then such Grantor
shall promptly determine the reason for such return and shall issue a credit memorandum to the Account Debtor in the appropriate amount. In the event any Account Debtor returns Inventory to such Grantor when an Event of Default exists, such Grantor,
upon the request of the Administrative Agent, shall: (i) hold the returned Inventory in trust for the Administrative Agent; (ii) segregate all returned Inventory from all of its other property; (iii) dispose of the returned Inventory
solely according to the Administrative Agent’s written instructions; and (iv) not issue any credits or allowances with respect thereto without the Administrative Agent’s prior written consent. All returned Inventory shall be subject
to the Administrative Agent’s Liens thereon. 
 (c) Inventory Count. Such Grantor will conduct or cause to be conducted a
physical count of its Inventory at least once per fiscal year, and after and during the continuation of an Event of Default, at such other times as the Administrative Agent requests. Such Grantor, at its own expense, shall deliver to the
Administrative Agent the results of each physical verification, which such Grantor has made, or has caused any other Person to make on its behalf, of all or any portion of its Inventory. 

(d) Equipment. Such Grantor shall not permit any Equipment to become a fixture with respect to real property or to become an accession
with respect to other personal property with respect to which real or personal property the Administrative Agent does not have a Lien. Such Grantor will not, without the Administrative Agent’s prior written consent, alter or remove any
identifying symbol or number on any of such Grantor’s Equipment constituting Collateral. 
 (e) Titled Vehicles. If requested by
the Administrative Agent, such Grantor will give the Administrative Agent notice of its acquisition of any vehicle covered by a certificate of title and deliver to the Administrative Agent, upon request, the original of any vehicle title certificate
and provide and/or file all other documents or instruments necessary to have the Lien of the Administrative Agent noted on any such certificate or with the appropriate state office. 

  
 10 








 4.4. Delivery of Instruments, Securities, Chattel Paper and Documents. Such Grantor will
(a) deliver to the Administrative Agent promptly upon execution of this Security Agreement the originals of all Securities and Instruments constituting Collateral owned by it (if any then exist), in each case solely to the extent such item of
Security, or Instrument exceeds $50,000 individually or $100,000 in the aggregate, (b) hold in trust for the Administrative Agent upon receipt and promptly thereafter deliver to the Administrative Agent any such Securities and Instruments
constituting Collateral, in each case solely to the extent such item of Security, or Instrument exceeds $50,000 individually or $100,000 in the aggregate and (c) upon the Administrative Agent’s request, deliver to the Administrative Agent
(and thereafter hold in trust for the Administrative Agent upon receipt and promptly deliver to the Administrative Agent) any Document evidencing or constituting Collateral. Such Grantor retains the originals of all Chattel Paper of such Grantor in
the possession of such Grantor at its principal place of business and will not deliver possession of any such Chattel Paper to any person; provided, that upon request of the Administrative Agent after and during the continuance of an Event of
Default, such Grantor will deliver such originals of all Chattel Paper to the Administrative Agent. 
 4.5. Uncertificated Pledged
Collateral. Such Grantor will permit the Administrative Agent from time to time to cause the appropriate issuers (and, if held with a securities intermediary, such securities intermediary) of uncertificated securities or other types of Pledged
Collateral owned by it not represented by certificates to mark their books and records with the numbers and face amounts of all such uncertificated securities or other types of Pledged Collateral not represented by certificates and all rollovers and
replacements therefor to reflect the Lien of the Administrative Agent granted pursuant to this Security Agreement. With respect to any Pledged Collateral owned by it, such Grantor will take any actions necessary to cause (a) the issuers of
uncertificated securities which are Pledged Collateral and (b) any securities intermediary which is the holder of any such Pledged Collateral, to cause the Administrative Agent to have and retain Control over such Pledged Collateral. Without
limiting the foregoing, such Grantor will, with respect to any such Pledged Collateral held with a securities intermediary, cause such securities intermediary to enter into a control agreement with the Administrative Agent, in form and substance
satisfactory to the Administrative Agent, giving the Administrative Agent Control. 
 4.6. Pledged Collateral. 

(a) Changes in Capital Structure of Issuers. Such Grantor will not (i) permit or suffer any issuer of an Equity Interest
constituting Pledged Collateral owned by it to dissolve, merge, liquidate, retire any of its Equity Interests or other Instruments or Securities evidencing ownership, reduce its capital, sell or encumber all or substantially all of its assets
(except for Permitted Encumbrances, sales of assets permitted pursuant to Section 4.1(d), and otherwise as permitted by the Credit Agreement) or merge or consolidate with any other entity, or (ii) vote any such Pledged
Collateral in favor of any of the foregoing. 
 (b) Issuance of Additional Securities. Such Grantor will not permit or suffer the
issuer of an Equity Interest constituting Pledged Collateral owned by it to issue additional Equity Interests, any right to receive the same or any right to receive earnings, except to such Grantor or as permitted by the Credit Agreement. 

(c) Registration of Pledged Collateral. Such Grantor will permit any registerable Pledged Collateral owned by it to be registered in
the name of the Administrative Agent or its nominee at any time at the option of the Required Lenders. 
 (d) Exercise of Rights in
Pledged Collateral. 
 (i) Without in any way limiting the foregoing and subject to clause (ii) below, such Grantor
shall have the right to exercise all voting rights or other rights relating to the Pledged Collateral 

  
 11 








 
owned by it for all purposes not inconsistent with this Security Agreement, the Credit Agreement or any other Loan Document; provided however, that no vote or other right shall be
exercised or action taken which would have the effect of impairing the rights of the Administrative Agent in respect of such Pledged Collateral. 

(ii) Such Grantor will permit the Administrative Agent or its nominee at any time after the occurrence and during the
continuance of an Event of Default, without notice, to exercise all voting rights or other rights relating to the Pledged Collateral owned by it, including, without limitation, exchange, subscription or any other rights, privileges, or options
pertaining to any Equity Interest or Investment Property constituting Pledged Collateral as if it were the absolute owner thereof. 

(iii) Such Grantor shall be entitled to collect and receive for its own use all cash dividends and interest paid in respect of
the Pledged Collateral owned by it, and cash payments in respect of principal of, or in redemption of, or in exchange for, such Pledged Collateral constituting an obligation of the Company to a Subsidiary or an obligation of a Subsidiary to the
Company or another Subsidiary, to the extent not in violation of the Credit Agreement other than any of the following distributions and payments (collectively referred to as the “Excluded Payments”): (A) dividends and
interest paid or payable other than in cash in respect of such Pledged Collateral, and instruments and other property received, receivable or otherwise distributed in respect of, or in exchange for, any Pledged Collateral; (B) dividends and
other distributions paid or payable in cash in respect of such Pledged Collateral in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or
paid-in capital of an issuer; and (C) cash paid, payable or otherwise distributed, in respect of principal of, or in redemption of, or in exchange for, such Pledged Collateral (excluding Pledged
Collateral constituting an obligation of the Company to a Subsidiary or an obligation of a Subsidiary to the Company or another Subsidiary); provided however, that until actually paid, all rights to such distributions shall remain subject to
the Lien created by this Security Agreement; and 
 (iv) All Excluded Payments and all other distributions in respect of any
of the Pledged Collateral owned by such Grantor, whenever paid or made, shall be delivered to the Administrative Agent to hold as Pledged Collateral and shall, if received by such Grantor, be received in trust for the benefit of the Administrative
Agent, be segregated from the other property or funds of such Grantor, and be forthwith delivered to the Administrative Agent as Pledged Collateral in the same form as so received (with any necessary endorsement). 

(e) Interests in Limited Liability Companies and Limited Partnerships. Each Grantor agrees that no ownership interests in a limited
liability company or a limited partnership which are included within the Collateral owned by such Grantor shall at any time constitute a Security under Article 8 of the UCC of the applicable jurisdiction. 

4.7. Intellectual Property. 

(a) Upon the reasonable request of the Administrative Agent, such Grantor will use its commercially reasonable efforts to secure all consents
and approvals necessary or appropriate for the assignment to or benefit of the Administrative Agent of any License held by such Grantor and to enforce the security interests granted hereunder. 

(b) Except as disclosed in Exhibit D, such Grantor shall notify the Administrative Agent promptly if it knows or has reason to know that any
application or registration relating to any material Patent, Trademark or Copyright (now or hereafter existing) may become abandoned or dedicated to the public, or of any adverse determination or development (including the institution of, or any
such determination or development in, any proceeding in the United States Patent and Trademark Office, the United States Copyright Office or any court) regarding such Grantor’s ownership of any Patent, Trademark or Copyright, its right to
register the same, or to keep and maintain the same. 

  
 12 








 (c) In no event shall such Grantor, either directly or through any agent, employee, licensee or
designee, file an application for the registration of any Patent, Trademark or Copyright with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency without giving the Administrative Agent
prior written notice thereof, and, upon request of the Administrative Agent, such Grantor shall execute and deliver any and all security agreements as the Administrative Agent may request to evidence the Administrative Agent’s first priority
security interest on such Patent, Trademark or Copyright, and the General Intangibles of such Grantor relating thereto or represented thereby. 

(d) Such Grantor shall take such actions as it deems appropriate in its reasonable business judgment to maintain and pursue each application,
to obtain the relevant registration and to maintain the registration of each of its Patents, Trademarks and Copyrights (now or hereafter existing), including the filing of applications for renewal, affidavits of use, affidavits of noncontestability
and opposition and interference and cancellation proceedings, unless such Grantor shall reasonably determine that such Patent, Trademark or Copyright is not material to the conduct of such Grantor’s business. 

(e) Such Grantor shall, take such actions as it reasonably determines are appropriate, in its reasonable business judgment, to enforce its
rights against any infringement, misappropriation or dilution and to recover any and all damages for such infringement, misappropriation or dilution, of the Patents, Trademarks and Copyrights that such Grantor reasonably determines are material to
its business. In the event that such Grantor institutes suit because any of its Patents, Trademarks or Copyrights constituting Collateral is infringed upon, or misappropriated or diluted by a third party, such Grantor shall comply with
Section 4.8. 
 4.8 Commercial Tort Claims. Such Grantor shall promptly, and in any event within five (5) Business Days
after the same is acquired by it, notify the Administrative Agent of any Commercial Tort Claim (other than any such Commercial Tort Claims not in excess of $50,000 individually or $100,000 in the aggregate) acquired by it and, unless the
Administrative Agent otherwise consents, such Grantor shall enter into an amendment to this Security Agreement, in the form of Exhibit J hereto, granting to Administrative Agent a first priority security interest in such commercial tort
claim. 
 4.9. Letter-of-Credit Rights. If such
Grantor is or becomes the beneficiary of a letter of credit, it shall promptly, and in any event within five (5) Business Days after becoming a beneficiary, notify the Administrative Agent thereof and use its commercially reasonable efforts to
cause the issuer and/or confirmation bank to (i) consent to the assignment of any Letter-of-Credit Rights to the Administrative Agent and (ii) agree to direct
all payments thereunder to a Deposit Account at the Administrative Agent or subject to a Deposit Account Control Agreement for application to the Secured Obligations, in accordance with Section 2.18 of the Credit Agreement, all in form and
substance reasonably satisfactory to the Administrative Agent. 
 4.10. Federal, State or Municipal Claims. Such Grantor will
promptly notify the Administrative Agent of any Collateral with a face value in excess of $50,000 individually or $100,000 in the aggregate which constitutes a claim against the United States government or any state or local government or any
instrumentality or agency thereof, the assignment of which claim is restricted by federal, state or municipal law. 
 4.11. No
Interference. Such Grantor agrees that it will not interfere with any right, power and remedy of the Administrative Agent exercised in good faith provided for in this Security Agreement or now or hereafter existing at law or in equity or by
statute or otherwise, or the exercise or beginning of the exercise by the Administrative Agent of any one or more of such rights, powers or remedies in good faith. 

4.12. Insurance. (a) In the event any Collateral is located in any area that has been designated by the Federal Emergency
Management Agency as a “Special Flood Hazard Area”, such Grantor shall purchase and maintain flood insurance on such Collateral (including any personal property which is located on any real property leased by such Loan Party within a
“Special Flood Hazard Area”). The amount of flood insurance required by this Section shall at a minimum comply with applicable law, including the Flood Disaster Protection Act of 1973, as amended. 

  
 13 








 (b) All insurance policies required hereunder and under Section 5.10 of the Credit Agreement
shall name the Administrative Agent (for the benefit of the Administrative Agent and the Secured Parties) as an additional insured or as lender’s loss payee, as applicable, and shall contain lender loss payable clauses or mortgagee clauses,
through endorsements in form and substance satisfactory to the Administrative Agent, which provide that: (i) all proceeds thereunder with respect to any Collateral shall be payable to the Administrative Agent; (ii) no such insurance shall
be affected by any act or neglect of the insured or owner of the property described in such policy; and (iii) such policy and lender loss payable or mortgagee clauses may be canceled, amended, or terminated only upon at least thirty
(30) days prior written notice given to the Administrative Agent. 
 (c) All premiums on any such insurance shall be paid when due
(subject to any grace periods provided by the terms of such policy) by such Grantor, and copies of the policies delivered to the Administrative Agent. If such Grantor fails to obtain or maintain any insurance as required by this Section, the
Administrative Agent may obtain such insurance at the Borrower’s expense. By purchasing such insurance, the Administrative Agent shall not be deemed to have waived any Default arising from the Grantor’s failure to maintain such insurance
or pay any premiums therefor. 
 4.13. Collateral Access Agreements. Such Grantor shall use commercially reasonable efforts to obtain
a Collateral Access Agreement from the lessor of each leased property, mortgagee of owned property or bailee or consignee with respect to any warehouse, processor or converter facility or other location where Collateral is stored or located, which
agreement or letter shall provide access rights, contain a waiver or subordination of all Liens or claims that the landlord, mortgagee, bailee or consignee may assert against the Collateral at that location, and shall otherwise be reasonably
satisfactory in form and substance to the Administrative Agent. 
 4.14. Deposit Account Control Agreements. Such Grantor will
provide to the Administrative Agent upon the Administrative Agent’s request, a Deposit Account Control Agreement duly executed on behalf of each financial institution holding a deposit account of such Grantor as set forth in this Security
Agreement (excluding Excluded Deposit and Securities Accounts). 
 4.15. Change of Name or Location; Change of Fiscal Year. Such
Grantor shall not (a) change its name as it appears in official filings in the state of its incorporation or organization, (b) change its chief executive office, principal place of business, mailing address, corporate offices or warehouses
or locations at which Collateral is held or stored, or the location of its records concerning the Collateral as set forth in this Security Agreement, (c) change the type of entity that it is, (d) change its organization identification
number, if any, issued by its state of incorporation or other organization, or (e) change its state of incorporation or organization, in each case, unless the Administrative Agent shall have received at least thirty (30) days prior written
notice of such change and the Administrative Agent shall have acknowledged in writing that either (1) such change will not adversely affect the validity, perfection or priority of the Administrative Agent’s security interest in the
Collateral, or (2) any reasonable action requested by the Administrative Agent in connection therewith has been completed or taken (including any action to continue the perfection of any Liens in favor of the Administrative Agent, on behalf of
the Secured Parties, in any Collateral) or will be taken within any time period reasonably specified by the Administrative Agent, provided that, any new location shall be in the continental U.S. Such Grantor shall not change its fiscal year
which currently ends on December 31. 

  
 14 








 ARTICLE V 

EVENTS OF DEFAULT AND REMEDIES 

5.1.    Events of Default. The occurrence of any one or more of the following events shall constitute an Event of
Default hereunder: 
 (a)    Any representation or warranty made by or on behalf of any Grantor under or in connection
with this Security Agreement shall be materially false as of the date on which made. 
 (b)    Any Grantor shall fail to
observe or perform any of the terms or provisions of Article IV. 
 (c)    Any Grantor shall fail to observe or
perform any of the terms or provisions of this Security Agreement (other than a breach which constitutes an Event of Default under any other Section of this Article V), and such failure shall continue unremedied for a period of ten
(10) Business Days after the earlier of knowledge of such breach or notice thereof from the Administrative Agent. 

(d)    The occurrence of any “Event of Default” under, and as defined in, the Credit Agreement (subject to any
applicable cure or grace periods). 
 (e)    Any Equity Interest which is included within the Collateral shall at any
time constitute a Security or the issuer of any such Equity Interest shall take any action to have such interests treated as a Security unless (i) all certificates or other documents constituting such Security have been delivered to the
Administrative Agent and such Security is properly defined as such under Article 8 of the UCC of the applicable jurisdiction, whether as a result of actions by the issuer thereof or otherwise, or (ii) the Administrative Agent has entered into a
control agreement with the issuer of such Security or with a securities intermediary relating to such Security and such Security is defined as such under Article 8 of the UCC of the applicable jurisdiction, whether as a result of actions by the
issuer thereof or otherwise. 
 5.2. Remedies. 

(a)    Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may exercise any or
all of the following rights and remedies: 
 (i)    those rights and remedies provided in this Security
Agreement, the Credit Agreement, or any other Loan Document; provided that, this Section 5.2(a) shall not be understood to limit any rights or remedies available to the Administrative Agent and the other Secured Parties prior to an Event
of Default; 
 (ii)    those rights and remedies available to a secured party under the UCC (whether or
not the UCC applies to the affected Collateral) or under any other applicable law (including, without limitation, any law governing the exercise of a bank’s right of setoff or bankers’ lien) when a debtor is in default under a security
agreement; 
 (iii)    give notice of sole control or any other instruction under any Deposit Account
Control Agreement or and other control agreement with any securities intermediary and take any action therein with respect to such Collateral; 

(iv)    without notice (except as specifically provided in Section 8.1 or elsewhere herein), demand or
advertisement of any kind to any Grantor or any other Person, enter the premises of any Grantor where any Collateral is located (through self-help and without judicial process) to collect, receive, assemble, process, appropriate, sell, lease,
assign, grant an option or options to purchase or otherwise dispose of, deliver, or realize upon, the Collateral or any part thereof in one or more parcels at public or private sale or sales (which sales may be adjourned or continued from time to
time with or without notice and may take place at any Grantor’s premises or elsewhere), for cash, on credit or for future delivery without assumption of any credit risk, and upon such other terms as the Administrative Agent may deem
commercially reasonable; and 

  
 15 








 (v)    concurrently with written notice to the applicable
Grantor, transfer and register in its name or in the name of its nominee the whole or any part of the Pledged Collateral, exchange certificates or instruments representing or evidencing Pledged Collateral for certificates or instruments of smaller
or larger denominations, exercise the voting and all other rights as a holder with respect thereto, to collect and receive all cash dividends, interest, principal and other distributions made thereon and to otherwise act with respect to the Pledged
Collateral as though the Administrative Agent was the outright owner thereof. 
 (b)    The Administrative Agent, on
behalf of the Secured Parties, may comply with any applicable state or federal law requirements in connection with a disposition of the Collateral and compliance will not be considered to adversely affect the commercial reasonableness of any sale of
the Collateral. 
 (c)    The Administrative Agent shall have the right upon any such public sale or sales and, to the
extent permitted by law, upon any such private sale or sales, to purchase for the benefit of the Administrative Agent and the other Secured Parties, the whole or any part of the Collateral so sold, free of any right of equity redemption, which
equity redemption the Grantor hereby expressly releases. 
 (d)    Until the Administrative Agent is able to effect a
sale, lease, or other disposition of Collateral, the Administrative Agent shall have the right to hold or use Collateral, or any part thereof, to the extent that it deems appropriate for the purpose of preserving Collateral or its value or for any
other purpose deemed appropriate by the Administrative Agent. The Administrative Agent may, if it so elects, seek the appointment of a receiver or keeper to take possession of Collateral and to enforce any of the Administrative Agent’s remedies
(for the benefit of the Administrative Agent and the other Secured Parties), with respect to such appointment without prior notice or hearing as to such appointment. 

(e)    If, after the Credit Agreement has terminated by its terms and all of the Obligations have been paid in full, there
remain Swap Agreement Obligations outstanding, the Required Lenders may exercise the remedies provided in this Section 5.2 upon the occurrence of any event which would allow or require the termination or acceleration of any Swap Agreement
Obligations pursuant to the terms of the Swap Agreement. 
 (f)    Notwithstanding the foregoing, neither the
Administrative Agent nor any other Secured Party shall be required to (i) make any demand upon, or pursue or exhaust any of its rights or remedies against, any Grantor, any other obligor, guarantor, pledgor or any other Person with respect to
the payment of the Secured Obligations or to pursue or exhaust any of its rights or remedies with respect to any Collateral therefor or any direct or indirect guarantee thereof, (ii) marshal the Collateral or any guarantee of the Secured
Obligations or to resort to the Collateral or any such guarantee in any particular order, or (iii) effect a public sale of any Collateral. 

(g)    Each Grantor recognizes that the Administrative Agent may be unable to effect a public sale of any or all the
Pledged Collateral and may be compelled to resort to one or more private sales thereof in accordance with clause (a) above. Each Grantor also acknowledges that any private sale may result in prices and other terms less favorable to the
seller than if such sale were a public sale and, notwithstanding such circumstances, agrees that any such private sale shall not be deemed to have been made in a commercially unreasonable manner solely by virtue of such sale being private. The
Administrative Agent shall be under no obligation to delay a sale of any of the Pledged Collateral for the period of time necessary to permit any Grantor or the issuer of the Pledged Collateral to register such securities for public sale under the
Securities Act of 1933, as amended, or under applicable state securities laws, even if the applicable Grantor and the issuer would agree to do so. 

  
 16 








 5.3.    Grantor’s Obligations Upon Default. Upon the request of
the Administrative Agent after the occurrence and during the continuance of a Default, each Grantor will: 

(a)    assemble and make available to the Administrative Agent the Collateral and all books and records relating thereto
at any place or places specified by the Administrative Agent, whether at a Grantor’s premises or elsewhere; 

(b)    permit the Administrative Agent, by the Administrative Agent’s representatives and agents, to enter, occupy
and use any premises where all or any part of the Collateral, or the books and records relating thereto, or both, are located, to take possession of all or any part of the Collateral or the books and records relating thereto, or both, to remove all
or any part of the Collateral or the books and records relating thereto, or both, and to conduct sales of the Collateral, without any obligation to pay the Grantor for such use and occupancy; 

(c)    prepare and file, or cause an issuer of Pledged Collateral to prepare and file, with the Securities and Exchange
Commission or any other applicable government agency, registration statements, a prospectus and such other documentation in connection with the Pledged Collateral as the Administrative Agent may request, all in form and substance satisfactory to the
Administrative Agent, and furnish to the Administrative Agent, or cause an issuer of Pledged Collateral to furnish to the Administrative Agent, any information regarding the Pledged Collateral in such detail as the Administrative Agent may specify;

 (d)    take, or cause an issuer of Pledged Collateral to take, any and all actions necessary to register or qualify
the Pledged Collateral to enable the Administrative Agent to consummate a public sale or other disposition of the Pledged Collateral; and 

(e)    at its own expense, cause the independent certified public accountants then engaged by each Grantor to prepare and
deliver to the Administrative Agent and each Lender, at any time, and from time to time, promptly upon the Administrative Agent’s request, the following reports with respect to the applicable Grantor: (i) a reconciliation of all Accounts;
(ii) an aging of all Accounts; (iii) trial balances; and (iv) a test verification of such Accounts. 

5.4.    Grant of Intellectual Property License. For the purpose of enabling the Administrative Agent to exercise
the rights and remedies under this Article V at such time as the Administrative Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby (a) grants to the Administrative Agent, for the benefit of the
Administrative Agent and the other Secured Parties, an irrevocable (subject to termination pursuant to Section 7.14), nonexclusive license (exercisable without payment of royalty or other compensation to any Grantor) to use, license or
sublicense any intellectual property rights now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored and to
all computer software and programs used for the compilation or printout thereof and (b) irrevocably agrees that the Administrative Agent may sell any of such Grantor’s Inventory directly to any person, including without limitation persons
who have previously purchased the Grantor’s Inventory from such Grantor and in connection with any such sale or other enforcement of the Administrative Agent’s rights under this Security Agreement, may sell Inventory which bears any
Trademark owned by or licensed to such Grantor and any Inventory that is covered by any Copyright owned by or licensed to such Grantor and the Administrative Agent may finish any work in process and affix any Trademark owned by or licensed to such
Grantor and sell such Inventory as provided herein. 
 ARTICLE VI 

ACCOUNT VERIFICATION; ATTORNEY IN FACT; PROXY 

6.1.    Account Verification. The Administrative Agent may at any time after the occurrence of an Event of Default,
in the Administrative Agent’s own name, in the name of a nominee of the Administrative Agent, or in the name of any Grantor communicate (by mail, telephone, facsimile or otherwise) with the 

  
 17 








 
Account Debtors of any such Grantor, parties to contracts with any such Grantor and obligors in respect of Instruments of any such Grantor to verify with such Persons, to the Administrative
Agent’s satisfaction, the existence, amount, terms of, and any other matter relating to, Accounts, Instruments, Chattel Paper, payment intangibles and/or other Receivables. 

6.2.    Authorization for Administrative Agent to Take Certain Action. 

(a)    After the occurrence and during the continuance of an Event of Default, each Grantor irrevocably authorizes the
Administrative Agent at any time and from time to time in the sole discretion of the Administrative Agent and appoints the Administrative Agent as its attorney-in-fact
(i) to endorse and collect any cash proceeds of the Collateral, (ii) to file any financing statement with respect to the Collateral and to file any other financing statement or amendment of a financing statement (which does not add new
collateral or add a debtor) in such offices as the Administrative Agent in its sole discretion deems necessary or desirable to perfect and to maintain the perfection and priority of the Administrative Agent’s security interest in the
Collateral, (iii) to contact and enter into one or more agreements with the issuers of uncertificated securities which are Pledged Collateral or with securities intermediaries holding Pledged Collateral as may be necessary or advisable to give
the Administrative Agent Control over such Pledged Collateral, (iv) to discharge past due taxes, assessments, charges, fees or Liens on the Collateral (except for such Liens that are permitted under Section 6.02 of the Credit Agreement),
(v) to contact Account Debtors for any reason, (vi) to demand payment or enforce payment of the Receivables in the name of the Administrative Agent or such Grantor and to endorse any and all checks, drafts, and other instruments for the payment
of money relating to the Receivables, (vii) to sign such Grantor’s name on any invoice or bill of lading relating to the Receivables, drafts against any Account Debtor of the Grantor, assignments and verifications of Receivables,
(viii) to exercise all of such Grantor’s rights and remedies with respect to the collection of the Receivables and any other Collateral, (ix) to settle, adjust, compromise, extend or renew the Receivables, (x) to settle, adjust
or compromise any legal proceedings brought to collect Receivables, (xi) to prepare, file and sign such Grantor’s name on a proof of claim in bankruptcy or similar document against any Account Debtor of such Grantor, (xii) to prepare,
file and sign such Grantor’s name on any notice of Lien, assignment or satisfaction of Lien or similar document in connection with the Receivables, (xiii) to change the address for delivery of mail addressed to such Grantor to such address
as the Administrative Agent may designate and to receive, open and dispose of all mail addressed to such Grantor, and (xiv) to do all other acts and things reasonably necessary to carry out this Security Agreement; and such Grantor agrees to
reimburse the Administrative Agent on demand for any reasonable, documented payment or expense made or incurred by the Administrative Agent in connection with any of the foregoing; provided that, this authorization shall not relieve such
Grantor of any of its obligations under this Security Agreement or under the Credit Agreement. 
 (b)    All acts of
said attorney or designee are hereby ratified and approved. The powers conferred on the Administrative Agent, for the benefit of the Administrative Agent and Secured Parties, under this Section 6.2 are solely to protect the Administrative
Agent’s interests in the Collateral and shall not impose any duty upon the Administrative Agent or any other Secured Party to exercise any such powers. The Administrative Agent agrees that, except for the powers granted in
Section 6.2(a)(i)-(iv) and Section 6.2(a)(xiv), it shall not exercise any power or authority granted to it unless an Event of Default has occurred and is continuing. 

6.3.    Proxy. EACH GRANTOR HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS THE ADMINISTRATIVE AGENT AS ITS PROXY AND ATTORNEY-IN-FACT (AS SET FORTH IN SECTION 6.2 ABOVE) OF THE GRANTOR WITH RESPECT TO ITS PLEDGED COLLATERAL, INCLUDING THE RIGHT TO VOTE SUCH PLEDGED COLLATERAL, WITH FULL
POWER OF SUBSTITUTION TO DO SO. IN ADDITION TO THE RIGHT TO VOTE ANY SUCH PLEDGED COLLATERAL, THE APPOINTMENT OF THE ADMINISTRATIVE AGENT AS PROXY AND ATTORNEY-IN-FACT
SHALL INCLUDE THE RIGHT TO EXERCISE ALL OTHER RIGHTS, POWERS, PRIVILEGES AND REMEDIES TO WHICH A HOLDER OF SUCH PLEDGED COLLATERAL WOULD BE ENTITLED (INCLUDING GIVING OR WITHHOLDING WRITTEN CONSENTS OF


  
 18 








 
SHAREHOLDERS, CALLING SPECIAL MEETINGS OF SHAREHOLDERS AND VOTING AT SUCH MEETINGS). SUCH PROXY SHALL BE EFFECTIVE, AUTOMATICALLY AND WITHOUT THE NECESSITY OF ANY ACTION (INCLUDING ANY TRANSFER
OF ANY SUCH PLEDGED COLLATERAL ON THE RECORD BOOKS OF THE ISSUER THEREOF) BY ANY PERSON (INCLUDING THE ISSUER OF SUCH PLEDGED COLLATERAL OR ANY OFFICER OR AGENT THEREOF), UPON THE OCCURRENCE AND DURING THE CONTINUATION OF A DEFAULT. 

6.4.    Nature of Appointment; Limitation of Duty. THE APPOINTMENT OF THE ADMINISTRATIVE AGENT AS PROXY AND ATTORNEY-IN-FACT IN THIS ARTICLE VI IS COUPLED WITH AN INTEREST AND SHALL BE IRREVOCABLE UNTIL THE DATE ON WHICH THIS SECURITY AGREEMENT IS TERMINATED IN ACCORDANCE WITH
SECTION 7.14. NOTWITHSTANDING ANYTHING CONTAINED HEREIN, NONE OF THE ADMINISTRATIVE AGENT, ANY LENDER, ANY OTHER SECURED PARTY, ANY OF THEIR RESPECTIVE AFFILIATES, OR ANY OF THEIR OR THEIR AFFILIATES’ RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES,
AGENTS OR REPRESENTATIVES SHALL HAVE ANY DUTY TO EXERCISE ANY RIGHT OR POWER GRANTED HEREUNDER OR OTHERWISE OR TO PRESERVE THE SAME AND SHALL NOT BE LIABLE FOR ANY FAILURE TO DO SO OR FOR ANY DELAY IN DOING SO, EXCEPT IN RESPECT OF DAMAGES
ATTRIBUTABLE SOLELY TO SUCH PARTY’S OWN GROSS NEGLIGENCE OR WILLFUL MISCONDUCT AS FINALLY DETERMINED BY A COURT OF COMPETENT JURISDICTION; PROVIDED THAT, IN NO EVENT SHALL THEY BE LIABLE FOR ANY PUNITIVE, EXEMPLARY, INDIRECT OR CONSEQUENTIAL
DAMAGES. 
 ARTICLE VII 

GENERAL PROVISIONS 

7.1    Waivers. Each Grantor hereby waives notice of the time and place of any public sale or the time after which
any private sale or other disposition of all or any part of the Collateral may be made. To the extent such notice may not be waived under applicable law, any notice made shall be deemed reasonable if sent to Grantors, addressed as set forth in
Article IX, at least ten (10) Business Days prior to (i) the date of any such public sale or (ii) the time after which any such private sale or other disposition may be made. To the maximum extent permitted by applicable law, each
Grantor waives all claims, damages, and demands against the Administrative Agent or any Secured Party arising out of the repossession, retention or sale of the Collateral, except such as arise solely out of the gross negligence or willful misconduct
of the Administrative Agent or such Secured Party as finally determined by a court of competent jurisdiction. To the extent it may lawfully do so, each Grantor absolutely and irrevocably waives and relinquishes the benefit and advantage of, and
covenants not to assert against the Administrative Agent or any other Secured Party, any valuation, stay, appraisal, extension, moratorium, redemption or similar laws and any and all rights or defenses it may have as a surety now or hereafter
existing which, but for this provision, might be applicable to the sale of any Collateral made under the judgment, order or decree of any court, or privately under the power of sale conferred by this Security Agreement, or otherwise. Except as
otherwise specifically provided herein, each Grantor hereby waives presentment, demand, protest or any notice (to the maximum extent permitted by applicable law) of any kind in connection with this Security Agreement or any Collateral. 

7.2.    Limitation on Administrative Agent’s and Secured Parties’ Duty with Respect to the Collateral.
The Administrative Agent shall have no obligation to clean-up or otherwise prepare the Collateral for sale. The Administrative Agent and each other Secured Party shall use reasonable care with respect to the
Collateral in its possession or under its control. Neither the Administrative Agent nor any other Secured Party shall have any other duty as to any Collateral in its possession or control or in the possession or control of any agent or nominee of
the Administrative Agent or such other Secured Party, or any income thereon or as to the preservation of rights against prior parties or any other rights pertaining thereto. To the extent that applicable law imposes duties on the Administrative
Agent to exercise remedies in a commercially reasonable manner, each Grantor acknowledges and agrees that it is commercially reasonable for the Administrative Agent (i) to fail to incur expenses deemed significant by the Administrative Agent to
prepare Collateral for disposition or 

  
 19 








 
otherwise to transform raw material or work in process into finished goods or other finished products for disposition, (ii) to fail to obtain third party consents for access to Collateral to
be disposed of, or to obtain or, if not required by other law, to fail to obtain governmental or third party consents for the collection or disposition of Collateral to be collected or disposed of, (iii) to fail to exercise collection remedies
against Account Debtors or other Persons obligated on Collateral or to remove Liens on or any adverse claims against Collateral, (iv) to exercise collection remedies against Account Debtors and other Persons obligated on Collateral directly or
through the use of collection agencies and other collection specialists, (v) to advertise dispositions of Collateral through publications or media of general circulation, whether or not the Collateral is of a specialized nature, (vi) to
contact other Persons, whether or not in the same business as such Grantor, for expressions of interest in acquiring all or any portion of such Collateral, (vii) to hire one or more professional auctioneers to assist in the disposition of
Collateral, whether or not the Collateral is of a specialized nature, (viii) to dispose of Collateral by utilizing internet sites that provide for the auction of assets of the types included in the Collateral or that have the reasonable
capacity of doing so, or that match buyers and sellers of assets, (ix) to dispose of assets in wholesale rather than retail markets, (x) to disclaim disposition warranties, such as title, possession or quiet enjoyment, (xi) to
purchase insurance or credit enhancements to insure the Administrative Agent against risks of loss, collection or disposition of Collateral or to provide to the Administrative Agent a guaranteed return from the collection or disposition of
Collateral, or (xii) to the extent reasonably deemed appropriate by the Administrative Agent, to obtain the services of other brokers, investment bankers, consultants and other professionals to assist the Administrative Agent in the collection
or disposition of any of the Collateral. The Grantor acknowledges that the purpose of this Section 7.2 is to provide non-exhaustive indications of what actions or omissions by the Administrative Agent
would be commercially reasonable in the Administrative Agent’s exercise of remedies against the Collateral and that other actions or omissions by the Administrative Agent shall not be deemed commercially unreasonable solely on account of not
being indicated in this Section 7.2. Without limitation upon the foregoing, nothing contained in this Section 7.2 shall be construed to grant any rights to the Grantor or to impose any duties on the Administrative Agent that would not have
been granted or imposed by this Security Agreement or by applicable law in the absence of this Section 7.2. 

7.3.    Compromises and Collection of Collateral. The Grantors and the Administrative Agent recognize that setoffs,
counterclaims, defenses and other claims may be asserted by obligors with respect to certain of the Receivables, that certain of the Receivables may be or become uncollectible in whole or in part and that the expense and probability of success in
litigating a disputed Receivable may exceed the amount that reasonably may be expected to be recovered with respect to a Receivable. In view of the foregoing, each Grantor agrees that the Administrative Agent may at any time and from time to time,
if an Event of Default has occurred and is continuing, compromise with the obligor on any Receivable, accept in full payment of any Receivable such amount as the Administrative Agent in its sole discretion shall determine or abandon any Receivable,
and any such action by the Administrative Agent shall be commercially reasonable so long as the Administrative Agent acts in good faith based on information known to it at the time it takes any such action. 

7.4.    Secured Party Performance of Debtor Obligations. Upon the occurrence and during the continuance of an Event
of Default, without having any obligation to do so, the Administrative Agent may perform or pay any obligation which any Grantor has agreed to perform or pay in this Security Agreement and the Grantors shall reimburse the Administrative Agent for
any reasonable, documented amounts paid by the Administrative Agent pursuant to this Section 7.4. The Grantors’ obligation to reimburse the Administrative Agent pursuant to the preceding sentence shall be a Secured Obligation payable on
demand. 
 7.5    Specific Performance of Certain Covenants. Each Grantor acknowledges and agrees that a breach
of any of the covenants contained in Sections 4.1(d), 4.1(e), 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 4.12, 4.13, 4.14, 4.15, 5.3, or 7.7 will cause irreparable injury to the Administrative Agent and the other Secured Parties, that the Administrative
Agent and the other Secured Parties have no adequate remedy at law in respect of such breaches and therefore agrees, without limiting the right of the Administrative Agent or the other Secured Parties to seek and obtain specific performance of other
obligations of the Grantors contained in this Security Agreement, that the covenants of the Grantors contained in the Sections referred to in this Section 7.5 shall be specifically enforceable against the Grantors. 

  
 20 








 7.6.    Dispositions Not Authorized. No Grantor is authorized to sell
or otherwise dispose of the Collateral except as set forth in Section 4.1(d) and notwithstanding any course of dealing between any Grantor and the Administrative Agent or other conduct of the Administrative Agent, no authorization to sell or
otherwise dispose of the Collateral (except as set forth in Section 4.1(d)) shall be binding upon the Administrative Agent or the other Secured Parties unless such authorization is in writing signed by the Administrative Agent with the consent
or at the direction of the Required Lenders. 
 7.7.    No Waiver; Amendments; Cumulative Remedies. No failure or
delay by the Administrative Agent or any other Secured Party in exercising any right or power under this Security Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or
discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent and the other Secured Parties hereunder are
cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Security Agreement or consent to any departure by the Grantor therefrom shall in any event be effective unless in writing
signed by the Administrative Agent with the concurrence or at the direction of the Lenders required under Section 9.02 of the Credit Agreement and then only to the extent in such writing specifically set forth. 

7.8.    Limitation by Law; Severability of Provisions. All rights, remedies and powers provided in this Security
Agreement may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and all the provisions of this Security Agreement are intended to be subject to all applicable mandatory provisions of law that
may be controlling and to be limited to the extent necessary so that they shall not render this Security Agreement invalid, unenforceable or not entitled to be recorded or registered, in whole or in part. Any provision in this Security Agreement
held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the
remaining provisions thereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction, and to this end the provisions of this Security Agreement are declared to be
severable.. 
 7.9    Reinstatement. This Security Agreement shall remain in full force and effect and continue
to be effective should any petition be filed by or against any Grantor for liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors or should a receiver or trustee be
appointed for all or any significant part of any Grantor’s assets, and shall continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Secured Obligations, or any part thereof (including a
payment effected through exercise of a right of setoff), is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Secured Obligations, whether as a “voidable
preference,” “fraudulent conveyance,” or otherwise (including pursuant to any settlement entered into by a Secured Party in its discretion), all as though such payment or performance had not been made. In the event that any payment,
or any part thereof (including a payment effected through exercise of a right of setoff), is rescinded, reduced, restored or returned, the Secured Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded,
reduced, restored or returned. 
 7.10.    Benefit of Agreement. The terms and provisions of this Security
Agreement shall be binding upon and inure to the benefit of the Grantors, the Administrative Agent and the other Secured Parties and their respective successors and assigns (including all persons who become bound as a debtor to this Security
Agreement), except that no Grantor shall have the right to assign its rights or delegate its obligations under this Security Agreement or any interest herein, without the prior written consent of the Administrative Agent. No sales of participations,
assignments, transfers, or other dispositions of any agreement governing the Secured Obligations or any portion thereof or interest therein shall in any manner impair the Lien granted to the Administrative Agent, for the benefit of the
Administrative Agent and the other Secured Parties, hereunder. 

  
 21 








 7.11.    Survival of Representations. All representations and
warranties of the Grantors contained in this Security Agreement shall survive the execution and delivery of this Security Agreement. 

7.12.    Taxes and Expenses. Any taxes (including income taxes) payable or ruled payable by Federal or State
authority in respect of this Security Agreement shall be paid by the Grantors, together with interest and penalties, if any. The Grantors shall reimburse the Administrative Agent for any and all out-of-pocket expenses and internal charges (including reasonable attorneys’, auditors’ and accountants’ fees and reasonable time charges of attorneys, paralegals, auditors and accountants who
may be employees of the Administrative Agent) paid or incurred by the Administrative Agent in connection with the preparation, execution, delivery, administration, collection and enforcement of this Security Agreement and, to the extent provided in
the Credit Agreement in the audit, analysis, administration, collection, preservation or sale of the Collateral (including the expenses and charges associated with any periodic or special audit of the Collateral required to be paid by the Credit
Agreement). Any and all costs and expenses incurred by the Grantors in the performance of actions required pursuant to the terms hereof shall be borne solely by the Grantors. 

7.13.    Headings. The title of and section headings in this Security Agreement are for convenience of reference
only, and shall not govern the interpretation of any of the terms and provisions of this Security Agreement. 

7.14.    Termination. This Security Agreement shall continue in effect (notwithstanding the fact that from time to
time there may be no Secured Obligations outstanding) until (i) the Credit Agreement has terminated pursuant to its express terms and (ii) all of the Secured Obligations other than contingent indemnification obligations as to which no
claim has been made have been indefeasibly paid and performed in full (or with respect to any outstanding Letters of Credit, a cash deposit has been delivered to the Administrative Agent as required by the Credit Agreement) and no commitments of the
Administrative Agent or the Lenders which would give rise to any Secured Obligations are outstanding. 

7.15.    Entire Agreement. This Security Agreement and the other Loan Documents embody the entire agreement and
understanding between the Grantors and the Administrative Agent relating to the Collateral and supersedes all prior agreements and understandings between the Grantors and the Administrative Agent relating to the Collateral. 

7.16.    CHOICE OF LAW. THIS SECURITY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE INTERNAL LAWS (AND NOT THE LAW OF CONFLICTS) OF THE STATE NEW YORK, BUT GIVING EFFECT TO FEDERAL LAWS APPLICABLE TO NATIONAL BANKS.  

7.17.    CONSENT TO JURISDICTION. EACH GRANTOR HEREBY IRREVOCABLY SUBMITS, FOR ITSELF AND ITS PROPERTY,
TO THE EXCLUSIVE JURISDICTION OF ANY U.S. FEDERAL OR NEW YORK STATE COURT SITTING IN NEW YORK, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT OR FOR RECOGNITION OR ENFORCEMENT OF
ANY JUDGMENT, AND EACH GRANTOR HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT AND IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT IT
MAY LEGALLY AND EFFECTIVELY DO SO, ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM. EACH OF THE PARTIES HERETO AGREES THAT A FINAL
JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING HEREIN SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY
LENDER TO BRING  

  
 22 








 
PROCEEDINGS AGAINST ANY GRANTOR IN THE COURTS OF ANY OTHER JURISDICTION. ANY JUDICIAL PROCEEDING BY ANY GRANTOR AGAINST THE ADMINISTRATIVE AGENT OR ANY LENDER OR ANY AFFILIATE OF THE
ADMINISTRATIVE AGENT OR ANY LENDER INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS SECURITY AGREEMENT OR ANY OTHER LOAN DOCUMENT SHALL BE BROUGHT ONLY IN A COURT IN NEW YORK, NEW YORK.

 7.18.    WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY
(WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OR OTHER AGENT (INCLUDING ANY ATTORNEY) OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS SECURITY AGREEMENT BY, AMONG OTHER
THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 
 7.19.    Indemnity. To the extent required
by Section 9.03 of the Credit Agreement, each Grantor hereby agrees to indemnify the Administrative Agent and the other Secured Parties, and their respective successors, assigns, agents and employees (each such Person, an
“Indemnitee”), from and against any and all liabilities, damages, penalties, suits, fees, costs, and expenses of any kind and nature (including, without limitation, all expenses of litigation or preparation therefor whether or not the
Administrative Agent or any Secured Party is a party thereto) imposed on, incurred by or asserted against the Administrative Agent or the other Secured Parties, or their respective successors, assigns, agents and employees, in any way relating to or
arising out of this Security Agreement, or the manufacture, purchase, acceptance, rejection, ownership, delivery, lease, possession, use, operation, condition, sale, return or other disposition of any Collateral (including, without limitation,
latent and other defects, whether or not discoverable by the Administrative Agent or the other Secured Parties or any Grantor, and any claim for Patent, Trademark or Copyright infringement); provided that such indemnity shall not, as to any
Indemnitee, be available to the extent that such losses, claims, damages, penalties, liabilities or related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from (i) the gross
negligence or willful misconduct of any Indemnitee, or (ii) a material breach in bad faith of any Loan Document by any Indemnitee 

7.20.    Counterparts. This Security Agreement may be executed in any number of counterparts, all of which taken
together shall constitute one agreement, and any of the parties hereto may execute this Security Agreement by signing any such counterpart. Delivery of an executed counterpart of a signature page of this Security Agreement by facsimile or other
electronic transmission shall be effective as delivery of a manually executed counterpart of this Security Agreement. 
 ARTICLE VIII

 NOTICES 

8.1.    Sending Notices. Any notice required or permitted to be given under this Security Agreement shall be sent
in accordance with Section 9.01 of the Credit Agreement. 
 8.2.    Change in Address for Notices. Each of
the Grantors, the Administrative Agent and the Lenders may change the address for service of notice upon it by a notice in writing to the other parties. 

  
 23 








 ARTICLE IX 

THE ADMINISTRATIVE AGENT 

JPMorgan Chase Bank, N.A. has been appointed Administrative Agent for the Lenders hereunder pursuant to Article VIII of the Credit Agreement.
It is expressly understood and agreed by the parties to this Security Agreement that any authority conferred upon the Administrative Agent hereunder is subject to the terms of the delegation of authority made by the Lenders to the Administrative
Agent pursuant to Article VIII of the Credit Agreement, and that the Administrative Agent has agreed to act (and any successor Administrative Agent shall act) as such hereunder only on the express conditions contained in such Article VIII. Any
successor Administrative Agent appointed pursuant to Article VIII of the Credit Agreement shall be entitled to all the rights, interests and benefits of the Administrative Agent hereunder. 

[Signature Page Follows] 

  
 24 








 IN WITNESS WHEREOF, the Grantors and the Administrative Agent have executed this Security
Agreement as of the date first above written. 
  

			
	GRANTORS:
	
	HESKA CORPORATION
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer
	
	DIAMOND ANIMAL HEALTH, INC.
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer
	
	HESKA IMAGING, LLC
		
	By:	 	 /s/ John McMahon

	Name: John McMahon
	Title: Chief Financial Officer









  

			
	ADMINISTRATIVE AGENT:
	
	JPMORGAN CHASE BANK, N.A.,
	as Administrative Agent


 
			
		
	By:	 	 /s/ *



 
			
	Name: * [Personal Identifying Information Omitted]
	Title: Authorized Officer









 EXHIBIT A 

(See Sections 3.2, 3.3, 3.4, 3.9 and 8.1 of Security Agreement) 

NOTICE ADDRESS FOR ALL GRANTORS 

3760 Rocky Mountain Avenue 

Loveland, CO 80538 

Attention: Chief Financial Officer 

Facsimile: 970-619-3003 

INFORMATION AND COLLATERAL LOCATIONS OF HESKA CORPORATION 
  

	I.	Name of Grantor: Heska Corporation 

  

	II.	State of Incorporation or Organization: Delaware 

  

	III.	Type of Entity: corporation 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 2733906 

  

	V.	Federal Identification Number: 77-0192527 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 


3760 Rocky Mountain Ave.     

Loveland, Colorado 80538     

Attention: John McMahon 
  

	VII.	Locations of Collateral: 

  

	 	(a)	Properties Owned by the Grantor: 

  

	 	    	1959 Big Sandy Place, Loveland, Colorado 80538 

  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	3760 Rocky Mountain Avenue, Loveland, Colorado 80538 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 


	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 








 INFORMATION AND COLLATERAL LOCATIONS OF DIAMOND ANIMAL HEALTH, INC. 

 

	I.	Name of Grantor: Diamond Animal Health, Inc. 

  

	II.	State of Incorporation or Organization: Iowa 

  

	III.	Type of Entity: corporation 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 170088 

  

	V.	Federal Identification Number: * [Personal Identifying Information Omitted] 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 


2538 SE 43rd Street 

Des Moines, Iowa 50327 

Attention: John McMahon 
  

	VII.	Locations of Collateral: 

  

	 	(a)	Properties Owned by the Grantor: 

 2538 SE 43rd Street, Des Moines, Iowa 50327 
 4334
170th Ave, Carlisle, Iowa 50047 
 4770
170th Ave, Carlisle, Iowa 50047 
 4592
170th Ave, Carlisle, Iowa 50047 
  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	None 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 


	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 








 INFORMATION AND COLLATERAL LOCATIONS OF HESKA IMAGING, LLC 

 

	I.	Name of Grantor: Heska Imaging, LLC 

  

	II.	State of Incorporation or Organization: Delaware 

  

	III.	Type of Entity: limited liability company 

  

	IV.	Organizational Number assigned by State of Incorporation or Organization: 5988696 

  

	V.	Federal Identification Number: * [Personal Identifying Information Omitted] 

  

	VI.	Place of Business (if it has only one) or Chief Executive Office (if more than one place of business) and Mailing Address: 


3760 Rocky Mountain Ave. 

Loveland, Colorado 80538 

Attention: John McMahon 
 VII. Locations of
Collateral: 
  

	 	(a)	Properties Owned by the Grantor: 

  

	 	    	None 

  

	 	(b)	Properties Leased by the Grantor (Include Landlord’s Name): 

  

	 	    	None 

  

	 	(c)	Public Warehouses or other Locations pursuant to Bailment or Consignment Arrangements 


	 	 	(include name of Warehouse Operator or other Bailee or Consignee): 

  

	 	    	None 








 EXHIBIT B 

(See Section 3.5 of Security Agreement) 

DEPOSIT ACCOUNTS 
 Pursuant to the terms of the
Credit Agreement, the accounts below will be transferred to JP Morgan Chase Bank, N.A. after the Effective Date. 
  

							
	Heska Corp	  	*	  	Wells Fargo	    	Operating Account
	Heska Corp	  	*	  	Wells Fargo	    	Cash Collateral Account
	Heska Corp	  	*	  	Wells Fargo	    	Cash Collateral Account - Merchant
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - EUR
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - JPY
	Heska Corp	  	*	  	Wells Fargo	    	Multi-Currency Account - CAD
	Heska Corp	  	*	  	Bank of the West	    	Flexible Spending
	Heska Imaging, LLC	  	*	  	Wells Fargo	    	Operating Account
	Heska Imaging, LLC	  	*	  	Wells Fargo	    	Cash Disbursement Account
	Diamond Animal Health	  	*	  	Wells Fargo	    	Operating Account

 * Personal identifying information omitted 







 EXHIBIT C 

(See Section 3.7 of Security Agreement) 

LETTER-OF-CREDIT RIGHTS 

None 







 EXHIBIT D 

(See Section 3.10 and 3.11 of Security Agreement) 

INTELLECTUAL PROPERTY RIGHTS 

PATENTS (1) 
  

							
	 Name of Grantor
	  	 Patent Description
	  	 Patent Number
	  	 Issue Date

	See Exhibit D-1	  		  		  	

 PATENT APPLICATIONS (1) 
  

							
	 Name of Grantor
	  	 Patent Application
	  	 Application Filing Date
	  	 Application Serial Number

	See Exhibit D-1	  		  		  	

 TRADEMARKS 
  

							
	 Name of Grantor
	  	 Trademark
	  	 Registration Date
	  	 Registration Number

	See Exhibit D-2	  		  		  	

 TRADEMARK APPLICATIONS 
  

							
	 Name of Grantor
	  	 Trademark Application
	  	 Application Filing Date
	  	 Application Serial Number

	See Exhibit D-2	  		  		  	

 COPYRIGHTS 
  

							
	 Name of Grantor
	  	 Copyright
	  	 Registration Date
	  	 Registration Number

	None	  		  		  	

 COPYRIGHT APPLICATIONS 
  

							
	 Name of Grantor
	  	 Copyright Application
	  	 Application Filing Date
	  	 Application Serial Number

	None	  		  		  	

 INTELLECTUAL PROPERTY LICENSES 
  

							
	 Name of Grantor
	  	 Name of Agreement
	  	 Date of Agreement
	  	 Parties to Agreement

	Heska Corporation	  	Collaboration and License Agreement	  	July 29, 1998	  	Heska Corporation and Ralston Purina Company (nka Nestle Purina Petcare Company)

  

	(1)	On an ongoing basis, and in the ordinary course of business, Heska Corporation evaluates its patent and patent application portfolio. As patents and/or patent applications come up for renewal, Heska Corporation
will evaluate whether a patent or patent application is material to the business of the Borrowers and whether such patent or patent application will be renewed. 








 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
2618-17-C2-PUS-1
	  	Ectoparasite Saliva Proteins	  	10/271,344	  	10/14/2002	  	7,166,693 B2	  	1/23/2007	  	ISSUED
	
2618-17-C5-PUS-1
	  	Ectoparasite Saliva Proteins and Apparatus to Collect Such Proteins	  	09/004,730	  	1/8/1998	  	6,485,968 B1	  	11/26/2002	  	ISSUED
	
2618-25-C1-2

	  	Flea Protease Proteins, Nucleic Acid Molecules and Uses Thereof	  	08/485,443	  	6/7/1995	  	6,146,870	  	11/14/2000	  	ISSUED
	
2618-25-C6
	  	Flea Protease Proteins, Nucleic Acid Molecules and Uses Thereof	  	09/032,215	  	2/27/1998	  	6,204,010 B1	  	3/20/2001	  	ISSUED
	
2618-43-1-1

	  	Anti-Parasitic Helminth Macrophage Migration Inhibitory Factor Antibodies and Uses Thereof	  	09/774,377	  	1/30/2001	  	6,455,039 B2	  	9/24/2002	  	ISSUED
	 2618-45-2
	  	Antiparasitic Helminth Larval Thiol Specific Antioxidant Antibodies and Uses Thereof	  	09/477,510	  	1/4/2000	  	6,489,448 B1	  	12/3/2002	  	ISSUED
	 AD-1
	  	Canine COX-2 Nucleic Acid Molecules and Uses Thereof	  	09/919,060	  	7/31/2001	  	6,638,744 B2	  	10/28/2003	  	ISSUED
	 AD-1-3
	  	Canine COX-2 Proteins and Uses Thereof	  	12/352,511	  	1/12/2009	  	7,666,641	  	2/23/2010	  	ISSUED
	 AL-2-C3
	  	Dermatophagoides Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/292,225	  	4/15/1999	  	6,455,686 B1	  	9/24/2002	  	ISSUED
	
AL-2-C3-1

	  	Novel Dermatophagoides Proteins and Uses Thereof	  	10/218,743	  	8/13/2002	  	7,256,263 B2	  	8/14/2007	  	ISSUED
	 AL-2-C4
	  	Novel Dermatophagoides Proteins and Uses Thereof	  	09/662,293	  	9/14/2000	  	7,128,921 B1	  	10/31/2006	  	ISSUED
	
AL-2-C4-1

	  	Novel Dermatophagoides Proteins and Uses Thereof	  	11/506,444	  	8/18/2006	  	7,891,187	  	9/15/2009	  	ISSUED
	 AL-4
	  	Feline Immunoglobulin E Molecules and Compositions Thereof	  	09/479,614	  	1/7/2000	  	6,573,372 B2	  	6/3/2003	  	ISSUED
	 AL-4-1
	  	Feline Immunoglobulin E Molecules and Related Methods	  	10/409,772	  	4/7/2003	  	7,183,386 B2	  	2/27/2007	  	ISSUED
	 AL-5
	  	Canine Low Affinity IgE Receptor (CD23) Nucleic Acid Molecules and Uses Thereof	  	09/535,521	  	3/24/2000	  	6,410,714 B1	  	6/25/2002	  	ISSUED









 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 AL-7
	  	Compositions and Methods Related to Canine IgG and Canine IL-13 Receptor	  	09/828,995	  	4/9/2001	  	6,703,360 B2	  	3/9/2004	  	ISSUED
	 AL-7-1
	  	Canine IL-13 Receptor Alpha-1 Subunit Nucleic Acid Molecules	  	10/753,159	  	1/7/2004	  	7,378,275 B2	  	5/27/2008	  	ISSUED
	 AS-1
	  	Detection of Anti-FcEpsilonR Autoantibodies in Asthmatics	  	08/985,863	  	12/5/1997	  	6,165,799	  	12/26/2000	  	ISSUED
	 DE-1
	  	Delivery Method for Recombinant Raccoon Poxvirus	  	09/018,798	  	2/4/1998	  	6,106,841	  	8/22/2000	  	ISSUED
	
DE-3-C2-PUS-1
	  	Cationic Lipid-Mediated Enhancement of Nucleic Acid Immunization of Cats	  	10/864,903	  	6/9/2004	  	7,314,627 B2	  	1/1/2008	  	ISSUED
	
DE-3-C2-PUS-2
	  	Cationic Lipid-Mediated Enhancement of Nucleic Acid Immunization of Cats	  	11/866,558	  	10/3/2007	  	8,029,776 B2	  	10/4/2011	  	ISSUED
	 DI-13-C2
	  	Methods for Detecting Early Renal Disease in Animals	  	10/112,648	  	3/28/2002	  	7,172,873 B2	  	2/6/2007	  	ISSUED
	
DI-13-C2-1

	  	Methods of Detecting Early Renal Disease in Animals	  	11/627,784	  	1/26/2007	  	7,935,495 B2	  	5/3/2011	  	ISSUED
	 DI-4
	  	Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules and Uses Thereof	  	09/015,734	  	1/29/1998	  	6,057,127	  	5/2/2000	  	ISSUED
	 DI-4-1
	  	Equine Fc Epsilon Receptor Alpha Chain Proteins and Uses Thereof	  	09/515,311	  	2/29/2000	  	6,582,701 B1	  	6/24/2003	  	ISSUED
	 DI-4-2
	  	Anti-Equine Fc Epsilon Receptor Alpha Chain Antibodies and Method to Detect IgE	  	10/434,817	  	5/8/2003	  	6,887,672 B2	  	5/3/2005	  	ISSUED
	 DI-4-3
	  	Equine Fc Epsilon Receptor Alpha Chain Protein	  	11/086,903	  	3/21/2005	  	7,226,996 B2	  	6/5/2007	  	ISSUED
	 DI-6-C1
	  	Haemobartonella PCR Methods and Materials	  	09/398,577	  	9/17/1999	  	6,518,020 B1	  	2/11/2003	  	ISSUED
	 DI-7-C1
	  	PCR Methods and Materials	  	09/398,179	  	9/17/1999	  	6,300,072 B1	  	10/9/2001	  	ISSUED
	 EQ-2
	  	Intranasal Delivery System	  	09/408,584	  	9/29/1999	  	6,398,774 B1	  	6/4/2002	  	ISSUED
	
EQ-2-C1-PUS

	  	Intranasal Delivery System	  	10/089,224	  	3/27/2002	  	7,204,822 B1	  	4/17/2007	  	ISSUED
	
EQ-2-C1-PUS-1
	  	Equine Intranasal Delivery System	  	10/941,727	  	9/15/2004	  	7,678,087 B2	  	3/16/2010	  	ISSUED









 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
FC-11-PUS-1

	  	Flea Octopamine Receptor Nucleic Acid Molecules, Proteins and Uses Thereof	  	12/200,456	  	8/28/2008	  	7,932,371 B2	  	4/26/2011	  	ISSUED
	 FC-2-1
	  	Serine Protease Inhibitor Nucleic Acid Molecules and Uses Thereof	  	09/005,352	  	1/9/1998	  	6,479,253 B1	  	11/12/2002	  	ISSUED
	 FC-3
	  	Novel Flea Epoxide Hydrolase Nucleic Acid Molecules, Proteins and Uses Thereof	  	08/989,510	  	12/12/1997	  	6,037,160	  	3/14/2000	  	ISSUED
	 FC-3-C1
	  	Flea Epoxide Hydrolase Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/182,816	  	10/29/1998	  	6,143,542	  	11/7/2000	  	ISSUED
	
FC-3-C1-1

	  	Flea Epoxide Hydrolase Proteins and Uses Thereof	  	09/471,528	  	12/27/1999	  	6,153,397	  	11/28/2000	  	ISSUED
	
FC-3-C1-2

	  	Anti-Flea Epoxide Hydrolase Antibodies and Uses Thereof	  	09/634,530	  	8/8/2000	  	6,290,958 B1	  	9/18/2001	  	ISSUED
	 FC-4
	  	Flea Ecdysone and Ultraspiracle Nucleic Acid Molecules, Proteins and Uses Thereof	  	09/435,019	  	11/5/1999	  	6,489,140 B1	  	12/3/2002	  	ISSUED
	 FC-4-2
	  	Flea Ultraspiracle Nucleic Acid Molecules and Uses Thereof	  	10/855,541	  	5/27/2004	  	7,208,589 B2	  	4/24/2007	  	ISSUED
	 FC-4-3
	  	Flea Ultraspiracle Nucleic Acid Molecules	  	11/697,551	  	4/6/2007	  	7,667,019	  	2/23/2010	  	ISSUED
	 FC-5-C1
	  	Flea Chitinase Nucleic Acid Molecules and Uses Thereof	  	09/545,814	  	4/7/2000	  	6,416,977 B1	  	7/9/2002	  	ISSUED
	
FC-6-C1-C1-1
	  	Flea Allantoinase Proteins and Uses Thereof	  	10/180,165	  	6/26/2002	  	6,905,682 B2	  	6/14/2005	  	ISSUED
	
FC-6-C2-2

	  	Flea Peritrophin Nucleic Acid Molecules	  	11/778,533	  	7/16/2007	  	7,662,622 B2	  	2/16/2010	  	ISSUED
	
FC-7-PUS-1

	  	Flea GABA Receptor Subunit Nucleic Acid Molecules	  	12/352,535	  	1/12/2009	  	8,268,976	  	9/18/2012	  	ISSUED
	
FC-8-C3-1

	  	Flea Head, Nerve Cord, Hindgut and Malpighian Tubule Nucleic Acid Molecules, Proteins and Uses Thereof	  	11/565,729	  	12/1/2006	  	8,088,903 B2	  	1/3/2012	  	ISSUED
	 FO-3-C1
	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	09/387,809	  	9/1/1999	  	6,203,825 B1	  	3/20/2001	  	ISSUED
	
HW-5-C1-1

	  	Dirofilaria and Brugia Ankyrin Proteins and Uses Thereof	  	09/557,034	  	4/21/2000	  	6,365,569 B1	  	4/2/2002	  	ISSUED









 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 HW-8
	  	Parasitic Helminth Cuticlin Nucleic Acid Molecules and Uses Thereof	  	09/323,427	  	6/1/1999	  	6,248,329 B1	  	6/19/2001	  	ISSUED
	 HW-8-1
	  	Parasitic Helminth Cuticlin Nucleic Acid Molecules and Uses Thereof	  	09/812,642	  	3/20/2001	  	6,368,600 B1	  	4/9/2002	  	ISSUED
	 HW-9
	  	Parasitic Helminth DiAg2 Proteins, Nucleic Acid Molecules, and Uses Thereof	  	09/361,434	  	7/27/1999	  	6,136,963	  	10/24/2000	  	ISSUED
	 HW-9-1
	  	Parasitic Helminth DiAg2 Proteins and Uses Thereof	  	09/635,025	  	8/4/2000	  	6,392,017 B1	  	5/21/2002	  	ISSUED
	
IM-1-C1-PUS-1
	  	Canine and Feline B7-2 Proteins, Compositions and Uses Thereof	  	10/790,396	  	3/1/2004	  	7,053,181 B2	  	5/30/2006	  	ISSUED
	
IM-2-C1-1

	  	Canine IL-4 Nucleic Acid Molecules and Uses Thereof	  	10/218,654	  	8/13/2002	  	7,078,506 B2	  	7/18/2006	  	ISSUED
	
IM-2-C1-2

	  	Feline Granulocyte Macrophage Colony Stimulating Factor Nucleic Acid Molecules	  	11/486,995	  	7/14/2006	  	7,780,959 B2	  	8/24/2010	  	ISSUED
	
IM-2-C1-3

	  	Feline Granulocyte Macrophage Colony Stimulating Factor Nucleic Acid Molecules	  	12/819,964	  	6/21/2010	  	8,263,559	  	9/11/2012	  	ISSUED
	
IM-2-C1-C1-1
	  	Canine IL-5 Nucleic Acid Molecules	  	10/787,382	  	2/24/2004	  	7,183,080 B2	  	2/27/2007	  	ISSUED
	
IM-2-C1-C1-2
	  	Canine IL-5 Proteins and Fragments Thereof	  	11/561,562	  	11/20/2006	  	7,427,661 B2	  	9/23/2008	  	ISSUED
	
IM-2-C1-R

	  	Canine IL-4 Immunoregulatory Proteins and Uses Thereof	  	10/916,286	  	8/11/2004	  	RE39,614 E
 (Reissue)
	  	05/08/2007
 (10/29/2002)
	  	ISSUED
	
IM-2-C2-1

	  	Canine IL-13 Nucleic Acid Molecules and Uses Thereof	  	10/262,439	  	9/30/2002	  	7,026,139 B2	  	4/11/2006	  	ISSUED
	
IM-2-C2-R

	  	Canine IL-13 Immunoregulatory Proteins and Uses Thereof	  	10/918,292	  	8/13/2004	  	RE40,374 E
 (Reissue)
	  	06/10/2008
 (11/19/2002)
	  	ISSUED
	 IM-5-1
	  	Feline IL-12 Single Chain Nucleic Acid Molecules	  	10/821,670	  	4/9/2004	  	7,205,143 B2	  	4/17/2007	  	ISSUED
	 IM-5-3
	  	Feline IL-18 Nucleic Acid Molecules	  	12/128,440	  	5/28/2008	  	7,928,197 B2	  	4/19/2011	  	ISSUED
	 IN-1-C5
	  	Electrode for Evaluating Cardiac Functions Via Esophagus	  	09/513,737	  	2/22/2000	  	6,438,400 B1	  	8/20/2002	  	ISSUED









 U.S. Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILE DATE	  	U.S. PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 TX-1-C2
	  	Methods for the Detection of Encysted Parasites	  	09/216,393	  	12/18/1998	  	6,514,694 B2	  	2/4/2003	  	ISSUED
	
TX-1-C2-1

	  	Methods for the Detection of Encysted Parasites	  	10/321,856	  	12/17/2002	  	7,052,899 B2	  	5/30/2006	  	ISSUED








 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  

													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
AL-2-C3-PAU

	  	Novel Dermatophagoides Nucleic Acid Molecules, Proteins and Uses Thereof	  	36521/99	  	4/16/1999	  	762249	  	10/2/2003	  	GRANTED
	
DI-13-C2-PEP

	  	Methods of Detecting Early Renal Disease in Animals	  	02733963.9	  	3/28/2002	  	02733963.9	  	12/16/2009	  	GRANTED
	 DI-1-CH
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-DE
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	69723860.1-08	  	7/30/2003	  	GRANTED
	 DI-1-DK
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-ES
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-FR
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-GB
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-IE
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	 DI-1-IT
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	0943097	  	7/30/2003	  	GRANTED
	
DI-1-PAU-1

	  	Method to Detect IgE	  	57951/01	  	11/24/1997	  	769954	  	5/27/2004	  	GRANTED
	 DI-1-PCA
	  	Method to Detect IgE	  	2,270,868	  	11/24/1997	  	2,270,868	  	1/24/2006	  	GRANTED
	 DI-1-PEP
	  	Method to Detect IgE	  	97949625.4	  	11/24/1997	  	943097	  	7/30/2003	  	GRANTED
	 DI-1-PJP
	  	Method to Detect IgE	  	10-526731	  	11/24/1997	  	3993245	  	8/3/2007	  	GRANTED
	 DI-2-PCA
	  	Novel Feline FC Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	2,273,855	  	12/16/1997	  	2,273,855	  	5/27/2003	  	GRANTED
	 DI-4-BE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-CH
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-DE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	National no. to
be assigned	  	7/14/2010	  	GRANTED
	 DI-4-DK
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED









 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	 DI-4-ES
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	2348971	  	7/14/2010	  	GRANTED
	 DI-4-FI
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-FR
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-GB
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-IE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-IT
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-NL
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-PAU
	  	Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	25674/99	  	1/28/1999	  	746218	  	8/1/2002	  	GRANTED
	 DI-4-PCA
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	2,319,310	  	1/28/1999	  	2,319,310	  	5/24/2011	  	GRANTED
	 DI-4-PEP
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-PT
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	1051491	  	7/14/2010	  	GRANTED
	 DI-4-SE
	  	Novel Equine Fc Epsilon Receptor Alpha Chain Nucleic Acid Molecules, Proteins and Uses Thereof	  	99905532.0	  	1/26/1999	  	99905532.0	  	7/14/2010	  	GRANTED
	
EQ-2-C1-PAU

	  	Intranasal Delivery System	  	77376/00	  	9/29/2000	  	774757	  	10/28/2004	  	GRANTED
	
EQ-2-C1-PAU-1
	  	Intranasal Delivery System	  	20044218666	  	10/7/2004	  	20044218666	  	12/14/2006	  	GRANTED
	
EQ-2-C1-PAU-2
	  	Intranasal Delivery System	  	2006236004	  	11/14/2006	  	2006236004	  	6/26/2008	  	GRANTED
	
EQ-2-C1-PCA

	  	Intranasal Delivery System	  	2,386,110	  	9/29/2000	  	2,386,110	  	5/30/2006	  	GRANTED









 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
EQ-2-C1-PCA-1
	  	Intranasal Delivery System	  	2,541,848	  	9/29/2000	  	2,541,848	  	12/2/2008	  	GRANTED
	
EQ-2-C1-PCA-2
	  	Intranasal Delivery System	  	2,640,663	  	9/25/2008	  	2,640,663	  	9/13/2011	  	GRANTED
	
FC-6-C1-PEP

	  	Flea Head, Nerve Cord, Hindgut and Malpighian Tubule Nucleic Acid Molecules, Proteins and Uses Thereof	  	918540.6	  	4/7/2000	  	1169343	  	5/24/2006	  	GRANTED
	
FC-6-C2-PEP

	  	Flea Peritrophin Nucleic Acid Molecules, Proteins and Uses Thereof	  	1977740.8	  	10/11/2001	  	1328662	  	9/8/2010	  	GRANTED
	
FO-3-C1-AT

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	E243943	  	7/2/2003	  	GRANTED
	
FO-3-C1-DE

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-ES

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-FR

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-GB

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-IT

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-NL

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED









 Foreign Issued Patents owned solely by Heska Corporation 

(as of June 12, 2017) 
  


													
	 HESKA FILE NUMBER
	  	 TITLE
	  	APPLICATION
NUMBER	  	FILING
DATE	  	GRANTED
PATENT
NUMBER	  	ISSUE
DATE	  	STATUS
	
FO-3-C1-PAU

	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	60252/99	  	9/1/1999	  	769669	  	5/13/2004	  	GRANTED
	
FO-3-C1-PCA

	  	Method and Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	2,342,861	  	9/1/1999	  	2,342,861	  	6/9/2009	  	GRANTED
	
FO-3-C1-PEP

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	1109457	  	7/2/2003	  	GRANTED
	
FO-3-C1-SE

	  	Method to Manufacture a Composition to Protect an Obligate Carnivore From a Disease of Abnormal Carbohydrate Metabolism	  	99968209.9	  	9/1/1999	  	01109457	  	7/2/2003	  	GRANTED








 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	 2618-105
	  	USA	  	IMMUCHECK	  	2,913,428	  	12/21/2004	  	75/912,501	  	2/8/2000	  	42	  	REGISTERED
	
2618-105-CTM
	  	European Union	  	IMMUCHECK	  	002685154	  	12/1/2003	  	002685154	  	4/3/2002	  	05, 42, 44	  	REGISTERED
	
2618-117-CH
	  	Switzerland	  	E-SCREEN	  	493 504	  	7/1/2002	  	252520.1	  	10/27/2000	  	10	  	REGISTERED
	
2618-117-CTM
	  	European Union	  	E-SCREEN	  	001933282	  	7/25/2003	  	001933282	  	10/27/2000	  	10	  	REGISTERED
	
2618-117-NO
	  	Norway	  	E-SCREEN	  	212129	  	12/6/2001	  	2000 13104	  	10/26/2000	  	10	  	REGISTERED
	
2618-122-JP
	  	Japan	  	HESKA in Katakana	  	4624176	  	11/22/2002	  	2001-112667	  	12/18/2001	  	05, 10, 42	  	REGISTERED
	
2618-123-HK
	  	Hong Kong	  	TRI-HEART	  	300580554	  	7/13/2006	  	300580554	  	2/14/2006	  	05	  	REGISTERED
	
2618-123-KR
	  	South Korea	  	TRI-HEART	  	40-0685701	  	11/15/2006	  	40-2006-0011110	  	3/3/2006	  	05	  	REGISTERED
	
2618-123-TH
	  	Thailand	  	TRI-HEART	  	TM269052	  	10/16/2007	  	619166	  	2/28/2006	  	05	  	REGISTERED
	
2618-123-TW
	  	Taiwan	  	TRI-HEART	  	1233979	  	11/1/2006	  	95006936	  	2/15/2006	  	05	  	REGISTERED
	
2618-123-TW-1

	  	Taiwan	  	TRI-HEART	  	1418709	  	7/16/2010	  	98047611	  	10/28/2009	  	05	  	REGISTERED
	
2618-130-AU
	  	Australia	  	E.R.D.-HEALTHSCREEN	  	953376	  	6/28/2004	  	953376	  	5/12/2003	  	10	  	REGISTERED
	
2618-130-CA
	  	Canada	  	E.R.D.-HEALTHSCREEN	  	TMA651,278	  	10/24/2005	  	1177640	  	5/12/2003	  	10	  	REGISTERED
	
2618-130-JP-1

	  	Japan	  	ERD -HEALTHSCREEN w/ Katakana	  	5141567	  	6/13/2008	  	2006-100052	  	10/27/2006	  	10	  	REGISTERED
	
2618-136-2
	  	USA	  	ERD	  	3,753,400	  	2/23/2010	  	78/981,276	  	2/23/2010	  	44	  	REGISTERED
	 2618-142
	  	USA	  	HEMATRUE	  	3,509,683	  	9/30/2008	  	77/243,946	  	8/1/2007	  	05, 10	  	REGISTERED
	
2618-142-CA
	  	Canada	  	HEMATRUE	  	TMA741650	  	9/9/2009	  	1,385,154	  	3/4/2008	  	05	  	REGISTERED
	 2618-143
	  	USA	  	HESKAVIEW INTEGRATED SOFTWARE	  	3,538,197	  	11/25/2008	  	77/273,909	  	9/7/2007	  	09	  	REGISTERED
	
2618-143-CA
	  	Canada	  	HESKAVIEW INTEGRATED SOFTWARE	  	TMA746550	  	8/31/2009	  	1,380,774	  	1/25/2008	  	09	  	REGISTERED
	 2618-41
	  	USA	  	HESKA	  	2,494,527	  	10/2/2001	  	75/034,381	  	12/19/1995	  	05, 42	  	REGISTERED
	 2618-41-1
	  	USA	  	HESKA	  	2,655,214	  	12/3/2002	  	75/420,172	  	1/20/1998	  	05	  	REGISTERED
	 2618-41-2
	  	USA	  	HESKA	  	2,177,633	  	7/28/1998	  	75/977,369	  	12/19/1995	  	42	  	REGISTERED
	 2618-41-3
	  	USA	  	HESKA	  	2,948,416	  	5/10/2005	  	76/144,611	  	10/10/2000	  	05	  	REGISTERED
	 2618-41-4
	  	USA	  	HESKA	  	2,474,543	  	7/31/2001	  	75/980,370	  	1/20/1998	  	10	  	REGISTERED
	 2618-41-5
	  	USA	  	HESKA	  	3,336,031	  	11/13/2007	  	78/531,627	  	12/13/2004	  	05	  	REGISTERED
	
2618-41-AU
	  	Australia	  	HESKA	  	702979	  	5/29/1997	  	702979	  	2/23/1996	  	05	  	REGISTERED
	
2618-41-AU-1

	  	Australia	  	HESKA	  	732620	  	2/9/1998	  	732620	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-AU-2

	  	Australia	  	HESKA	  	890675	  	8/5/2002	  	890675	  	9/28/2001	  	10	  	REGISTERED
	
2618-41-BR
	  	Brazil	  	HESKA	  	819225568	  	10/17/2000	  	819225568	  	5/10/1996	  	05	  	REGISTERED
	
2618-41-BR-2

	  	Brazil	  	HESKA	  	830902880	  	6/17/2014	  	830902880	  	1/11/2011	  	10	  	REGISTERED
	
2618-41-CA
	  	Canada	  	HESKA	  	TMA558,841	  	3/6/2002	  	805330	  	2/26/1996	  	05	  	REGISTERED
	
2618-41-CA-1

	  	Canada	  	HESKA	  	TMA545,654	  	5/28/2001	  	842405	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-CA-2

	  	Canada	  	HESKA	  	TMA574,232	  	1/22/2003	  	1,096,586	  	3/20/2001	  	10, 31	  	REGISTERED
	
2618-41-CH
	  	Switzerland	  	HESKA	  	444 805	  	9/22/1997	  	01478/1996	  	3/4/1996	  	05, 10	  	REGISTERED
	
2618-41-CH-1

	  	Switzerland	  	HESKA	  	446 156	  	11/17/1997	  	03226/1997	  	4/24/1997	  	42	  	REGISTERED








 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	
2618-41-CN
	  	China	  	HESKA	  	1068630	  	8/7/1997	  	960038820	  	3/21/1996	  	05	  	REGISTERED
	
2618-41-CN-2

	  	China	  	HESKA	  	1906801	  	8/7/2002	  	2001056270	  	4/11/2001	  	05	  	REGISTERED
	
2618-41-CN-3

	  	China	  	HESKA	  	2015580	  	9/21/2002	  	2001056271	  	4/11/2001	  	42	  	REGISTERED
	
2618-41-CO
	  	Colombia	  	HESKA	  	218815	  	7/8/1999	  	98056943	  	9/30/1998	  	05	  	REGISTERED
	
2618-41-CTM
	  	European Union	  	HESKA	  	35055	  	9/6/1999	  	35055	  	4/1/1996	  	05	  	REGISTERED
	
2618-41-CTM-1

	  	European Union	  	HESKA	  	521740	  	12/14/1998	  	521740	  	4/16/1997	  	42	  	REGISTERED
	
2618-41-HK-3

	  	Hong Kong	  	HESKA	  	200200488AA	  	12/4/2000	  	200200488AA	  	12/4/2000	  	05, 10, 42	  	REGISTERED
	
2618-41-JP
	  	Japan	  	HESKA	  	4638918	  	1/25/2003	  	8-32003	  	3/25/1996	  	05	  	REGISTERED
	
2618-41-JP-1

	  	Japan	  	HESKA	  	4215403	  	11/27/1998	  	9-120112	  	5/23/1997	  	42	  	REGISTERED
	
2618-41-KR
	  	South Korea	  	HESKA	  	40-0714321	  	6/21/2007	  	40-2006-0011109	  	3/3/2006	  	10	  	REGISTERED
	
2618-41-MX-4

	  	Mexico	  	HESKA	  	1260578	  	1/16/2012	  	1146865	  	1/11/2011	  	05	  	REGISTERED
	
2618-41-NO
	  	Norway	  	HESKA	  	197881	  	6/9/1999	  	96.1270	  	3/27/1996	  	05	  	REGISTERED
	
2618-41-NO-1

	  	Norway	  	HESKA	  	187509	  	12/18/1997	  	97.3116	  	4/17/1997	  	42	  	REGISTERED
	
2618-41-NZ
	  	New Zealand	  	HESKA	  	259206	  	7/30/1998	  	259206	  	2/26/1996	  	05	  	REGISTERED
	
2618-41-NZ-2

	  	New Zealand	  	HESKA	  	708642	  	2/25/2004	  	708642	  	2/25/2004	  	44	  	REGISTERED
	
2618-41-SG
	  	Singapore	  	HESKA	  	T96/02766Z	  	12/19/1995	  	T96/02766Z	  	3/22/1996	  	05	  	REGISTERED
	
2618-41-SG-1

	  	Singapore	  	HESKA	  	T97/05350H	  	5/8/1997	  	T97/05350H	  	5/8/1997	  	42	  	REGISTERED
	
2618-41-TH
	  	Thailand	  	HESKA	  	269424	  	10/22/2007	  	619165	  	2/28/2006	  	05	  	REGISTERED
	
2618-41-TW
	  	Taiwan	  	HESKA	  	756827	  	4/16/1997	  	(85)9563	  	2/29/1996	  	05	  	REGISTERED
	
2618-41-TW-1

	  	Taiwan	  	HESKA	  	097332	  	1/31/1998	  	(86)19642	  	4/11/1997	  	42	  	REGISTERED
	 2618-51
	  	USA	  	HESKA AND DESIGN	  	2,628,459	  	10/1/2002	  	75/189,883	  	10/30/1996	  	05,42	  	REGISTERED
	 2618-51-1
	  	USA	  	HESKA AND DESIGN	  	2,623,862	  	9/24/2002	  	76/221,281	  	3/7/2001	  	10	  	REGISTERED
	
2618-51-AU
	  	Australia	  	HESKA AND DESIGN	  	730379	  	1/30/1998	  	730379	  	3/20/1997	  	05, 42	  	REGISTERED
	
2618-51-AU-1

	  	Australia	  	HESKA AND DESIGN	  	890674	  	5/8/2002	  	890674	  	9/28/2001	  	10	  	REGISTERED
	
2618-51-BR-1

	  	Brazil	  	HESKA AND DESIGN	  	819954926	  	12/14/1999	  	819905496	  	4/30/1997	  	44	  	REGISTERED
	
2618-51-CA
	  	Canada	  	HESKA AND DESIGN	  	TMA559,861	  	4/3/2002	  	840115	  	3/21/1997	  	05, 42	  	REGISTERED
	
2618-51-CA-1

	  	Canada	  	HESKA AND DESIGN	  	TMA574,233	  	1/22/2003	  	1096585	  	3/20/2001	  	10, 31	  	REGISTERED
	
2618-51-CH
	  	Switzerland	  	HESKA AND DESIGN	  	445 463	  	10/22/1997	  	2677/1997	  	4/7/1997	  	05, 10, 42	  	REGISTERED
	
2618-51-CN-2

	  	China	  	HESKA AND DESIGN	  	1906799	  	9/21/2002	  	2001056260	  	4/11/2001	  	05	  	REGISTERED
	
2618-51-CN-3

	  	China	  	HESKA AND DESIGN	  	2015583	  	9/21/2002	  	2001056261	  	4/11/2001	  	42	  	REGISTERED
	
2618-51-CTM
	  	European Union	  	HESKA AND DESIGN	  	494021	  	11/4/1998	  	494021	  	3/20/1997	  	05, 42	  	REGISTERED
	
2618-51-HK-3

	  	Hong Kong	  	HESKA AND DESIGN	  	200106759AA	  	12/4/2000	  	200106759AA	  	12/4/2000	  	05, 10, 42	  	REGISTERED
	
2618-51-JP
	  	Japan	  	HESKA AND DESIGN	  	4638919	  	1/25/2003	  	9-111471	  	4/25/1997	  	05	  	REGISTERED
	
2618-51-JP-1

	  	Japan	  	HESKA AND DESIGN	  	4215387	  	11/27/1998	  	9-111472	  	4/25/1997	  	42	  	REGISTERED
	
2618-51-NO
	  	Norway	  	HESKA AND DESIGN	  	200166	  	11/11/1999	  	19972388	  	3/21/1997	  	05, 42	  	REGISTERED
	
2618-51-NZ
	  	New Zealand	  	HESKA AND DESIGN	  	274355	  	10/30/1996	  	274355	  	3/20/1997	  	05	  	REGISTERED
	
2618-51-NZ-1

	  	New Zealand	  	HESKA AND DESIGN	  	274356	  	10/30/1996	  	274356	  	3/20/1997	  	42	  	REGISTERED
	
2618-51-TW
	  	Taiwan	  	HESKA AND DESIGN	  	816354	  	9/16/1998	  	(86)17443	  	4/11/1997	  	05	  	REGISTERED








 U.S. and Foreign Registered Trademarks and Pending Trademark Applications owned solely by Heska Corporation 

(as of June 12, 2017) 
  

																	
	 HESKA FILE
NUMBER
	  	 COUNTRY
	  	 TRADEMARK
	  	 REGISTRATION
NUMBER
	  	REGISTRATION
DATE	  	APPLICATION
NUMBER	  	FILING
DATE	  	CLASS (ES)	  	 STATUS

	
2618-51-TW-1

	  	Taiwan	  	HESKA AND DESIGN	  	097209	  	1/1/1998	  	(86)17444	  	4/11/1997	  	42	  	REGISTERED
	
2618-51-VE
	  	Venezuela	  	HESKA AND DESIGN	  	P-213.369	  	6/8/1999	  	5.952/97	  	4/1/1997	  	05	  	REGISTERED
	
2618-51-VE-1

	  	Venezuela	  	HESKA AND DESIGN	  	S-10.293	  	6/8/1999	  	5.953/97	  	4/1/1997	  	42	  	REGISTERED
	 2618-63
	  	USA	  	ALLERCEPT	  	2,612,937	  	8/27/2002	  	75/325,290	  	7/16/1997	  	05	  	REGISTERED
	 2618-63-2
	  	USA	  	ALLERCEPT	  	2,530,646	  	1/15/2002	  	75/980,372	  	7/16/1997	  	42	  	REGISTERED
	
2618-63-AU
	  	Australia	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-CA
	  	Canada	  	ALLERCEPT	  		  		  	1631209	  	6/14/2013	  	05, 44	  	REGISTERED
	
2618-63-CH
	  	Switzerland	  	ALLERCEPT	  	501047	  	7/16/2002	  	8557/2001	  	8/30/2001	  	05, 44	  	REGISTERED
	
2618-63-CN
	  	China	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-CTM
	  	European Union	  	ALLERCEPT	  	620138	  	11/18/1999	  	620138	  	8/29/1997	  	05, 42	  	REGISTERED
	
2618-63-JP
	  	Japan	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-MX
	  	Mexico	  	ALLERCEPT	  	1546775	  	6/15/2015	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-NO
	  	Norway	  	ALLERCEPT	  	212.574	  	12/27/2001	  	2001 10495	  	8/31/2001	  	05, 42	  	REGISTERED
	
2618-63-NZ
	  	New Zealand	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-PL
	  	Poland	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	
2618-63-RU
	  	Russia	  	ALLERCEPT	  	1190788	  	8/14/2015	  	1190788	  	6/10/2013	  	44	  	REGISTERED
	
2618-63-SG
	  	Singapore	  	ALLERCEPT	  		  		  	1190788	  	6/10/2013	  	05, 44	  	PENDING
	
2618-63-KR
	  	South Korea	  	ALLERCEPT	  	1190788	  	6/10/2013	  	1190788	  	6/10/2013	  	05, 44	  	REGISTERED
	 2618-76-3
	  	USA	  	SOLO STEP	  	2,509,741	  	11/20/2001	  	76/169,305	  	11/21/2000	  	10	  	REGISTERED
	
2618-76-3-CA

	  	Canada	  	SOLO STEP	  	TMA636,108	  	3/24/2005	  	1136071	  	5/7/2002	  	10	  	REGISTERED
	
2618-76-JP
	  	Japan	  	SOLO STEP	  	4406804	  	8/4/2000	  	11-88921	  	9/29/1999	  	10	  	REGISTERED
	
2618-76-JP-1

	  	Japan	  	SOLO STEP w/ Katakana	  	4454194	  	2/16/2001	  	2000-24733	  	3/14/2000	  	05, 10	  	REGISTERED
	 2618-96
	  	USA	  	VET/SENSOR	  	2,454,228	  	5/22/2001	  	75/612,052	  	12/21/1998	  	10	  	REGISTERED
	 2618-170
	  	USA	  	VITALPATH	  	3,908,910	  	1/18/2011	  	77/830223	  	9/18/2009	  	10	  	REGISTERED
	
2618-170-CA
	  	CANADA	  	VITALPATH	  	841,936	  	1/13/2013	  	1,478,308	  	3/16/2010	  	10	  	REGISTERED
	 2618-207
	  	USA	  	ELEMENT DC	  	4,318,224	  	4/9/2013	  	85/501,345	  	12/21/2011	  	10	  	REGISTERED
	 2618-209
	  	USA	  	ELEMENT i	  	4,851,518	  	11/10/2015	  	85/531,712	  	2/2/2012	  	10	  	REGISTERED
	 2618-213
	  	USA	  	ELEMENT POC	  	4,550,666	  	6/17/2014	  	86/062,771	  	9/12/2013	  	10	  	REGISTERED
	 2618-215
	  	USA	  	ELEMENT HT5	  	4,849,883	  	11/10/2015	  	86/548,170	  	2/27/2015	  	05, 10	  	REGISTERED
	
2618-215-AU
	  	Australia	  	ELEMENT HT5	  	1728208	  	1/28/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-CH
	  	Switzerland	  	ELEMENT HT5	  	1268876	  	3/25/2017	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-CTM
	  	European Union	  	ELEMENT HT5	  	1268876	  	8/17/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	
2618-215-NO
	  	Norway	  	ELEMENT HT5	  	1268876	  	9/16/2016	  	1268876	  	10/15/2015	  	05, 10	  	PENDING
	
2618-215-NZ
	  	New Zealand	  	ELEMENT HT5	  	1029762	  	1/3/2016	  	1268876	  	10/15/2015	  	05, 10	  	REGISTERED
	 T00014US0
	  	USA	  	DIAMOND AND DESIGN	  	1917148	  	9/5/1995	  	74-491,987	  	2/18/1994	  	5	  	REGISTERED








 EXHIBIT E 

(See Section 3.11 of Security Agreement) 

TITLE DOCUMENTS 
 I. Vehicles subject to
certificates of title: 
  

							
	 Name of Grantor
	  	 Description
	  	 Title Number
	  	 State Where Issued

	None	  		  		  	

 II. Aircraft/engines/parts, ships, railcars and other vehicles governed by federal statute: 

 

					
	 Name of Grantor
	  	 Description
	  	 Registration Number

	None	  		  	








 EXHIBIT F 

(See Section 3.11 of Security Agreement) 

FIXTURES 
 I. Legal description, county and
street address of property on which Fixtures are located (by Grantor): 
  

							
	 Address
	  	Type	  	Owned/Leased	  	Borrower
	 3760 Rocky Mountain Avenue,
 Loveland, Colorado
80538
	  	Building	  	Leased	  	Heska Corporation
	 1959 Big Sandy Place,
 Loveland, Colorado
80538
	  	Townhome	  	Owned	  	Heska Corporation
	 2538 SE 43rd Street
 Des Moines, Iowa
50327
	  	Building	  	Owned	  	Diamond Animal
Health
	 4334 170th Ave
 Carlisle, Iowa 50047

4770 170th Ave
 Carlisle, Iowa 50047
	  	Farm	  	Owned	  	Diamond Animal
Health
	 4592 170th Ave
 Carlisle, Iowa 50047
	  	Residence	  	Owned	  	Diamond Animal
Health

 II. Name and Address of Record Owner: 

Millbrae Square Company 
 717 Broadway, 

Millbrae, CA 94030 







 EXHIBIT G 

(See Section 3.13 of Security Agreement and Definition of “Pledged Collateral”) 

LIST OF PLEDGED COLLATERAL, SECURITIES AND OTHER INVESTMENT PROPERTY 

STOCKS 
  

											
	 Name of Grantor
	  	 Issuer
	  	Certificate
Number(s)	  	 Number of Shares
	  	 Class of Stock
	  	Percentage of
Outstanding
Shares
	Heska Corporation	  	Diamond Animal Health, Inc.	  	32	  	100	  	Common Stock	  	100%
	Heska Corporation	  	Heska Imaging, LLC	  	N/A	  	100% of Percentage Interests	  	Percentage Interests	  	100%
	Heska Corporation	  	Heska AG	  	N/A	  		  		  	100%
	Heska Corporation	  	Heska Canada Limited	  	N/A	  	1	  	Common	  	100%

 BONDS 
  

											
	 Name of Grantor
	  	 Issuer
	  	 Number
	  	 Face Amount
	  	 Coupon Rate
	  	 Maturity

	None	  		  		  		  		  	

 GOVERNMENT SECURITIES 
  

													
	 Name of Grantor
	  	 Issuer
	  	 Number
	  	 Type
	  	 Face Amount
	  	 Coupon Rate
	  	 Maturity

	None	  		  		  		  		  		  	

 OTHER SECURITIES OR OTHER INVESTMENT PROPERTY 

(CERTIFICATED AND UNCERTIFICATED) 
  

							
	 Name of Grantor
	  	 Issuer
	  	 Description of Collateral
	  	 Percentage Ownership

Interest

	None	  		  		  	








 EXHIBIT H 

(See Section 3.1 of Security Agreement) 

OFFICES IN WHICH FINANCING STATEMENTS HAVE BEEN FILED 

Colorado 
 Iowa 

Delaware 







 EXHIBIT I 

(See Definition of “Commercial Tort Claim”) 

COMMERCIAL TORT CLAIMS 
 {NOTE:
SPECIFICALLY DESCRIBE THE CLAIM (I.E. PARTIES, DESCRIPTION OF THE 
 DISPUTE, CASE NUMBER – IF AVAILABLE) - SEE OFFICIAL COMMENT 5
TO SECTION 9-108 
 OF THE UCC}. 

 

							
	 Name of Grantor
	  	 Description of Claim
	  	 Parties
	  	 Case Number; Name of Court

where Case was Filed

	None	  		  		  	








 EXHIBIT J 

(See Section 4.8 of Security Agreement) 

AMENDMENT 
 This Amendment, dated
                        ,              is delivered
pursuant to Section 4.8 of the Security Agreement referred to below. All defined terms herein shall have the meanings ascribed thereto or incorporated by reference in the Security Agreement. The undersigned hereby certifies that the
representations and warranties in Article III of the Security Agreement are and continue to be true and correct. The undersigned further agrees that this Amendment may be attached to that certain Pledge and Security Agreement, dated
                        ,             , between the
undersigned, as the Grantors, and JPMorgan Chase Bank, N.A., as the Administrative Agent, (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Security Agreement”) and that the
Collateral listed on Schedule I to this Amendment shall be and become a part of the Collateral referred to in said Security Agreement and shall secure all Secured Obligations referred to in the Security Agreement. 

 

							
	      

 

		
	By:	 	
	Name:	 		 		 	          

	Title:	 		 	          










 Schedule I to Amendment to Security Agreement 

COMMERCIAL TORT CLAIMS 
 {NOTE:
SPECIFICALLY DESCRIBE THE CLAIM (I.E. PARTIES, DESCRIPTION OF THE 
 DISPUTE, CASE NUMBER – IF AVAILABLE) - SEE OFFICIAL COMMENT 5
TO SECTION 9-108 
 OF THE UCC}. 

 

							
	 Name of Grantor
	  	 Description of Claim
	  	 Parties
	  	 Case Number; Name of
Court
where Case was Filed